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This study addresses the hypothesis that the following cell adhesion molecules
(CAMs):

homing-associated

(VLA-4)

and L-selecti

cell adhesion molecule (HCAM), very late antigen-4

I
I .
.
n p ay a ro e m the trafficking of hematopoietic progenitor cells

(HPCs) between the bone marrow microenvironment
order to ascertain differences
expression

In

in CAM expression based on physiologic compartment, the

of HCAM, VLA-4 or L-selectin per CD34+ myeloid progenitor cell was

assessed

between paired samples of blood and marrow. CAM expression was flow

cytometrically
mobilizing
donors

and the peripheral circulation.

quantitated

in paired samples obtained from patients treated with

doses of granulocyte-colony

donating for allogeneic

CD34+ myeloid progenitor

stimulating factor (G-CSF) or from normal

transplant.

In G-CSF mobilized patients, marrow derived

cells expressed more VLA-4 per cell than those in circulation.

In normal donors, marrow derived myeloid progenitor cells expressed more CD34 per
cell than those in circulation.
CAM expressing
forming

demonstrate the hematopoietic potential of

(HCAM+, VLA-4+ or L-selectin+) CD34+ myeloid progenitors, colony

unit (CFU) and long term culture initiating cell (LTCIC) assays of flow

cytometrically
performed.
BFU-E

To functionally

sorted normal marrow and blood CAM+!-CD34+myeloid progenitors were
L-selectin+CD34+

myeloid progenitors formed a greater percentage of

colonies and a lower percentage of CFU-GM colonies than all other CAM+!-

CD34+ myeloid progenitors
.
.
myeloid progerutors

sorte

.
cells than those denved

l d In normal donors, CAM+!-CD34+
sorted from norma I b 00.

df

rom

blood formed significantly more colonies per 10· plated

from marrow.

L-selectin+CD34+ myeloid progenitors derived

. d . .fi antly more L TCIC (per 10· sorted CAM+CD34+ myeloid
from marrow contame
srgni IC
x

progenitors)

than those expressing RCAM or VLA-4. In order to determine whether

CD34+ myeloid progenitors
assays were performed
progenitors

utilize VLA-4 to bind to fibronectin (FN), in vitro binding

Adhesion of normal blood derived VLA-4+ CD34+ myeloid

to FN was blocked by the addition of monoclonal antibodies against the a4

subunit of VLA-4.

These data suggest a model ofHPC trafficking, in which HPCs

utilize VLA-4 to adhere to components of the bone marrow microenvironment, while

HPe

modulation

of L-selectin

direct role in hematopoietic

affinity plays an important role in HPC homing and a less

reconstitution.
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INTRODUCTION

Basics of hematopoiesis-a

Hematopoiesis,
process dependent

historical narrative

the production and development of blood cells, is a complex

upon the existence of hematopoietic

hematopoietic

stem cell is capable of self-renewal

hematopoietic

system, a characteristic

ancestral

stem cells. By definition, a

and replenishing all lineages of the

known as pluripotency. The concept of a common

stem cell was first proposed almost a century ago by Artur Pappenheim

(1870-1916).

I

Since that time, compelling evidence has accumulated to support the
stem cell2-4 Using genetically identical mice, Lorenz et al.

concept of a hematopoietic

found that irradiated mice could be rescued from death with marrow from a nonirradiated
believed

mouse.' The hematopoietic

reconstitution

in the marrow transplanted mice was

to be due to the transfer of either a cellular component or a humoral component

within the marrow graft.
with the T6-marker
reconstitution,

To address this issue, Ford et al. transplanted marrow labeled

chromosome

the hematopoietic

be positive for the T6-marker

into irradiated mice. After hematopoietic
cells of the rescued mice were found to

chromosome.'

This study showed that a cellular component

. .
bei
transfierred from the marrow graft to the transplant recipient.
of donor origin was emg
1

Whether a single cell t
reconstitution
(centers

post-transpl

t ti
"
an a Ion remained unclear. By studying the splenic nodules

of hematopoiesis),

researchers

which form in irradiated mice post-transplantation,

found a linear relationship between the number of normal marrow cells

transplanted
colonies

" d
ype or a rnixe cell type was responsible for hematopoietic

and the number of splenic nodules formed." That is, the number of splenic

formed quantitatively

progenitor

reflected the number of stem cells or hematopoietic

cells (HPCs) contained within the transplanted graft. Further study of this

model system revealed that the cells of each splenic nodule were clonogenically
identical.

The infusion of cells from one nodule into another irradiated mouse resulted in

splenic nodules of cells cytogenetically
nodule.Y

identical to the cells of the originally transplanted

Spleen colony (colony forming unit-spleen,

confirmed

CFU-S) assays such as these

that a cellular component was being transferred in the graft and suggested that

reconstitution

of hematopoietic

lineages could result from a single cell type.

In response to the inability to apply the CFU-S assay clinically, as well as the
tediousness
developed.P
marrow

in vitro colony forming unit (CFU) assays were

involved in its execution,

CFU assays involve seeding cells from a stem cell source such as bone

"
"I" Id rna triIX in the presence of growth factors known to stimulate
II1to
a semi-so

lineage-specific
migration
responsive

hematopoietic

differentiation.

The semi-solid matrix prohibits the

of daughter ce IIs away from the point of seeding of the original growth factor
parent cell. Thus a group

of cells (a colony) represents all of the progeny of

I the hematopoietic
one parent ce.II 0 n y
supplemented

cells able to respond to growth factor

"
hil the unresponsive hematopoietic cells
in the media form colomes, w I e
2

presumably die. For example, the addition of the growth factor erythropoietin to the
culture media results in the formation of two types of erythroid colonies known as burst
forming unit-erythroid (BFU-E) or colony forming unit-erythroid (CFU-E). Likewise,
the addition of the growth factor granulocyte macrophage-colony stimulating factor
(GM-CSF) to the culture media results in the formation of myeloid colonies known as
colony forming unit-granulocyte macrophage (CFU-GM). The formation of BFU-E or
CFU-E colonies in vitro indicates the potential of seeded cells to restore erythroid cells,
while the formation of CFU-GM colonies indicate the potential of seeded cells to restore
the granulocytic and monocytic myeloid lineages. Studies using CFU assays have shown
that cells from the mononuclear fraction of mammalian bone marrow, peripheral blood
and cord blood can give rise to myeloid lineages when cultured in the presence of
lineage-specific growth factors."
To observe, in an in vitro setting, the long-term hematopoietic potential of cells
from the mononuclear fraction of mammalian bone marrow, long term bone marrow
cultures (LTBMCs) were developed. 10 Subsequently, LTBMCs have been adapted such
that the long-term hematopoietic potential of cells from the mononuclear fraction of
peripheral blood and cord blood may be observed. LTBMCs are established by culturing
nucleated marrow cells in a specifically defined media until confluent. The confluent
.
. ting
radiation-sensitive pluripotent HPCs while sparing
cultures are ndden
of contamma
III
.,

.,

the stromal cells via irradiation.

II

Cells from a stem cell source to be analyzed (marrow,

. d' d tromal cultures and begin to proliferate and
blood, etc.) are plated onto the irra late s
differentiate.

d' hanges cells which are no longer bound by the
During weekly half me ia c
,
3

stromal elements in the L TBMC
determine

their clonogenic

cells after L TBMC d
myeloid

lineages.

media containing
performed

are collected and analyzed with CFU assays to

potential.

emonstrate

Lymphoid

The formation of CFU colonies from nonadherent

..
the ability of cells within a stem cell source to restore

lineage restoration may be assessed via long-term culture in

fetal calf serum and no exogenous steroids.ll,12

in this manner have demonstrated

bone marrow, peripheral

L TBMC assays

that mononuclear cells derived from either

blood or cord blood contain pluripotent hematopoietic cell

types.
Recall that hematopoietic
self-renewal.
in conjunction

Maintenance

stem cells by definition are pluripotent and capable of

of L TBMCs plated in limiting dilutions of a stem cell source

with CFU assays, in the form of long term culture initiating cell (LTCIC)

assays, enables retrospective

extrapolation

the assayed product (e.g. mononuclear

of the number of stem cells contained within

cells from marrow).

The ability of cultured cells

to form CFU colonies at the end of the LTBMC portion of the L TCIC assay (i.e" after 5
weeks or more of culture) demonstrates
can maintain

long term hematopoiesis

. . stem ce.II
hematopoietic

that the cells within the originally seeded product
and possess clonogenic potential indicative of a

13 l

'

As suggested by LTBMC and LTCIC assays, long-term hematopoiesis in vitro
results from expansion of a single cell type which adheres to a supportive stromal layer
and requires stimulation

with specific hematopoietic

demonstrated
LTBMC stroma I ce 11 Iayers has
cytokines

growth factors.

15,16

Analysis of

that stromal cells produce a variety of

.
for hematopoietic
in vitro which are necessary
4

cell adherence."

These data

support the concept that norm Ih
"
a ematopOlesls depends upon the presence of a
pluripotent

stem cell, adhesion to str

oma, and a complex orchestration of growth factor

production

Hematopoietic

stem cel1 transplant

With the advent of several successful allogeneic marrow transplants in pediatric
patients with immunodeficiencies
transplantation

in the late 1960's, hematopoietic stem cell

became a feasible clinical therapy for the treatment of

hernatopathologies."?"

At the present time, hematopoietic

applied to a variety of hematologic
pathologies

and genetical1y

transplantation

determined diseases.

as a therapeutic

the patient is administered

myeloablative

blood and cord blood.

The rationale for stem cell

(chemotherapy

and/or radiation) therapy, the

destroyed and the patient is rescued with a graft

HPCs which repopulate

HPCs may be harvested

[6

malignancies, benign

modality for patients with malignancies is as follows:

marrow HPCs are concomitantly
containing

and nonhematologic

stem cell transplants are being

the marrow and restore hematopoiesis.

from a variety of sources including marrow, peripheral

Autologous

stem cel1 transplant involves harvest of the patient's

own HPCs either from marrow or apheresis of peripheral blood which are cryostored and
returned

after myeloablative

therapy.

Marrow HPCs may be harvested via aspiration of

. .
it of a patient or donor under general anesthesia. Blood HPCs
the iliac crest marrow cavi y
.
d thr gh ccessive phereses. Since HPCs represent a relatively
are typIcally harveste
ou
su
5

small fraction of mononUclear cells from marrow (1.5%) and blood (less than 0.5%), the
overall pool of HPCs available for harvest may be increased prior to harvest via
administration of growth factor therapies.i'<'

Growth factor therapies prior to HPC

harvest might include, but are not limited to, treatment with hematopoietic growth factors
such as granulocyte-colony
macrophage-colony

stimulating factor (G-CSF) or granulocyte

stimulating factor (GM-CSF).

A nonexhaustive list of stem cell

processing procedures which may be used prior to infusion includes red blood cell
salvage, T-cell depletion (allogeneic transplants only), tumor cell purging (autologous
transplants only) and CD34+ cell enrichment (both autologous and allogeneic
transplants).

The stem cell product, regardless of source, may be cryopreserveduntil

time of transplant when it is thawed and intravenously infused into the transplant
recipient.

Post-transplant hematologic recovery

Hematologic. recovery or post-transplantation engraftrnent involves the homing
.
'ofuse d HPCs to the marrow microenvironment and establishment of
of Intravenously
I

hematopoiesis.

Hematologic. recovery entails both clinical and long-term hematologic

f
the restoration of mature hematologiccells in
engraftrnent. Clinical engraftrnent re ers t0

the peripheral circulation post-transplantation.
engraftrnent occurs within 10-14 days 0

Under optimal conditions, clinical

f i travenous infusion of a stem cell graft.
10

..
. no t a consensus definition,
c linical engraftment is most frequently
Although there IS
6

reported to have Occurred on th f t d
h
e Irs ay t at the following peripheral blood counts have
been maintained for at least th

.
ree consecutive days: absolute neutrophil count greater

than 500 per microliter and total platelet count of 20,000 per microliter without
transfusion supportA>

Long-term engraftment refers to the restoration of the transplant

recipient's marrow stem cell population such that normal hematopoiesis is maintained for
at least one year post-transplant.

13

In a recent study of patients who received bone

marrow grafts transfected with a neomycin resistance marker gene, Brenner et al. was
able to demonstrate that autologous marrow infusion restores long-term hematopoiesis in
cancer patients for up to 18 months post-transplant." Brenner's findings demonstrate that
stem cell rescue in humans occurs through repopulation of the host marrow compartment
with donor hematopoietic cells; however, these findings do not rule out the possibility
that the patient's own stem cells surviving high-dose chemotherapy and/or radiotherapy
could also be contributing to hematopoietic recovery post-transplantation.
The most common post-transplantation complications include graft-versus-host
disease (allogeneic transplants only) and infection (both allogeneic and autologous
transplants) followed by venoclusive disease, graft failure, and disease relapse."
Manipulation of several parameters lessens the likelihood of these complications.
. . . c ctions of the immunocompromised transplant recipient may
Successful opportumsuc
mre

d ost-transplantation procedures. Prior to transplant,
be lessened through severa I pre- an p
. .
.
fficient numbers of CD34+ cells (a marker
the graft may be optimized to contam su
.

I 1-5 x 106 cells per kilogram of recipient weight, and

indicative of HPCs), approximate y

. .
ti Ito restore myeloid cells), approximately 1-5 x
sufficient CFU-GMs (indicates poten ia
7

10' cells per kilogram of recipient weight. 26,27 In addition, the high-dose chemotherapy
regimen administered prior to transplant can affect post-transplant hematologic recovery
rates. 28 The period of severe neutropenia and thrombocytopenia suffered prior to clinical
engraftment may be significantly shortened through administration of growth factor
therapies and specific stem cell sources. Growth factors such as G-CSF or GM-CSF are
often administered post-transplant to accelerate granulocyte recovery. The mechanism
by which these growth factors speed granulocyte recovery is not known but is believed to
occur by stimulating CFU-GMs infused in the graft to differentiate.P
In the past two decades the probability of curing a patient via stem cell
transplantation has improved steadily depending on the type and stage of disease.16 Thus,
hematopoietic stem cell transplantation remains a feasible clinical therapy for the
acceleration of hematologic recovery after cytoreductive therapies.

The hematopoietic microenvironment and cell adhesion molecules

.
. I eVIidence that the marrow microenvironment is crucial for the
There ISsubstantia
..
growth and differentiation of hernatopotetic
ce IIs.30-33 The marrow microenvironment
.'
consists of HPCs, hematopoieuc
celis at various stages of differentiation,
non-hematopoietic cells, soluble factors sue h as cytokines and growth factors, and
. ns. e to all mature blood cell types.
, (ECM) . HPCs give
extracellular matrix
,

Non-hematopoteietiIC cells or stromal cells compnse

at least four different subsets, as

d i I de endothelial cells, macrophages,
,
identified in in VItro
marrow cultures , an me u
8

adipocytes

fibroblasts.32

and pre-adipocytic

Ill, IV, and V; fibronectin;
glycosarninoglycans

haemonectin;

The marrow ECM contains collagen types I,

proteoglycans;

(GAGs, such as chondroitin

hyaluronic acid and

sulfate and heparin sulfate}."

In studies using long term bone marrow cultures, researchers have demonstrated
the in vitro necessity for hematopoietic

with specific growth factors for maintenance of long-term hematopoiesis in

conjunction
IO 33
•

cell adherence to supportive stromal layers in

vitro.

These findings

promotes

long-term

suggest that hematopoietic

hematopoiesis

toward long term hematopoietic

cell adhesion coupled with cytokines

and further suggest that adhesion is an important step
reconstitution.

However, little is known concerning the

identity and role of cell adhesion molecules which are important during hematopoiesis
Possible roles for cell adhesion molecules (CAMs) in normal hematopoiesis and

in hematopoietic

reconstituion

peripheralization

and homing of HPCs, presentation

regulation

after hematopoietic

stem cell transplant include
of growth factors to HPCs and

of mature blood cell egress from the marrow as they differentiate.

Understanding

the mechanisms

marrow microenvironment

governing the trafficking ofHPCs

would clarify some of these aspects ofHPC physiology and

prove beneficial to stem cell transplantation
masking of key cell adhesion
microenvironment
peripheralization

therapy.

For example,

down regulation or

molecules involved in HPC adhesion to the marrow

.
di HPC peripheralization.
might expe ite
.
bl th development
process might ena e e

·
tary mobilization
comp Iirnen

to and from the

Thus understanding the
of more efficient and efficacious

.
h currently available. Optimization ofHPC
regImens t an

9

homing to the bone marrow micr
problem of optimizing

Hematopoietic

progenitor

is critical to the

cell peripheralization

by which hematopoietic

from the marrow microenvironment
the differential

maturation

post-transplantation

hem t I .
a 0 ogre recovery following stem cell transplant.

The mechanism(s)

analyzing

.
oenvlronment

progenitor cells are peripheralized

into the blood is unclear. However, studies

surface expression of CAMs during hematopoietic cell

have suggested

a role for these molecules in the trafficking of HPCs to and

from the bone marrow microenvironment.tv" Of the CAMs known to mediate HPC
interactions

with the marrow microenvironment,

glycoproteins,

the role of homing-associated

very late antigen-4 (VLA-4,
cell-to-stroma
molecules

interactions

play an important

HCAM is involved
several extracellular
fibronectin.t?"

CD49d/CD29),

cell adhesion molecule (HCAMlCD44),
and L-selectin (CD62L) in cell-to-cell and

in the bone marrow strongly suggests that these cell adhesion
role in HPC peripheralization.v"
in mature lymphocyte

matrix components

VLA-4 , which is known to bind fibronectin,
Decreased

.
expression

f VLA 4

circulation

by altering fibronectin

-

trafficking and is known to bind to

including collagen, hyaluronic acid and

In vivo and in vitro experiments

0

including integrins and cell surface

have shown that the expression of

decreases as myeloid progenitors mature.

ight aid the egress of these cells into the peripheral
rm
,
bilit 35 This concept is supported by in vivo
bind 109 a I I y.

, ,
hi h th blockage ofVLA-4
murine and primate studies 10 w IC
e
10

mediated binding ofHPCs

via administration of monoclonal anti-VLA-4 antl'bod
It d '.
.
y resu e In an IncreaseIn the
numbers of circulating HPCS.39,40These studies suggest that VLA-4 might play an
important role in the peripheralization of myeloid progenitor cells. L-selectin has been
shown to playa critical role in the 'homing' of mature lymphocytes to peripheral lymph
nodes and is expressed on a variety of mature and immature HPCS.41-43In a comparative
study of bone marrow and leukopheresis samples from patients who had received
chemotherapy followed by granulocyte-colony stimulating factor (G-CSF) treatment, the
proportion of circulating CD34+ HPCs expressing L-selectin tended

to

be greater in

leukapheresis products than in marrow." These studies suggest that L-selectin might play
an important role in CD34+ HPC homing to the marrow microenvironment.
In spite of the many advances in the field of stem cell transplant therapy, many

problems remain. Two specific problems are the quality of mobilization of
hematopoietic cells into the peripheral circulation for collection and the role of stem cell
homing to the marrow in post-transplant hematopoietic recovery. Understanding the role
that CAMs play in HPC peripheralization and homing could lead to the development of
enhanced stem cell collection protocols and post-transplant engraftrnent rates,
respectively.

Current model ofHPC peripheralization

..
to cell adhesion molecules on
Although the bulk of research pertammg
hematopoietic cells strongly suggests that H

CAM, VLA-4 and L-selectin expression on

11

HPCs might be involved in h
.
t e penpheralization ofCD34+ HPC
mechanisms and cell adhesion
for HPC peripheralization

,

h
.
s, t e specific

.
molecules mvolved remain unclear. In the current model

HPc

.
expressIOn ofRCAM could enable binding to collagens

and hyaluronic acid, components of h
.
t e the marrow mIcroenvironment (Figure I). HPCs
expressing VLA-4 could bind to fib
.
I ronectm, a component of the marrow
microenvironment,

and VCAM I
- , expressed on stromal and endothelial cells. Once

released into the vasculature

,

HPC

homing functions of L-selectin.

s cou

Id h

orne to the marrow microenvironment via the

Thus changes in VLA-4 and/or RCAM expressIOnon
.

HPCs, as a result of down-regulation or masking of cell adhesion molecule function,
could result in egress from the marrow microenvironment; while up-regulation or
changes in ligand binding affinity ofL-selectin expressed on HPCs could result in ingress
into the marrow microenvironment.
In order to determine if cell adhesion molecule modulation is involved in HPC
peripheralization, the present study was designed to address the manner in which RCAM,
VLA-4 and L-selectin are involved in the trafficking of hematopoietic progenitor cells
between the marrow microenvironment and the peripheral circulation First, this study
illuminates the quantitative and qualitative differences in CAM (RCAM, VLA-4 or
L-selectin) expression on CD34+ HPCs from the blood and marrow ofG-CSF mobilized
patients or normal individuals.

Second, the role of CAM mediated adhesion of HPCs

regarding in vitro c1onogenic potential, ability to establish long-term hematopoiesisand
. .
II
tent of each CAM+CD34+HPC subset was
overall pluripotent hematopoieuc stem ce con
.
determined.

.
'1'
f CD34 +myeloid progenitor cells to bind to fibronectin, a
Third, the abi ity 0
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;:l

constituent of the bone marrow microenvironment, via the integrin VLA-4, was
analyzed in in vitro adhesion assays. These studies provide insight into the role of cell
adhesion molecules in hematopoietic progenitor cell trafficking between the marrow
microenvironment

and the peripheral circulation.

OBJECTIVES

Hypothesis

Modulation of the expression of th e f0 IIowing
' cell adhesion
, molecules: homingassociated cell adhesion molecule, very late antigen-4 , and Lit'
-se ec

In

'
p Iay a role In

regulating the trafficking o f poluri
unpotent hematopoietic progenitor cells between the bone
marrow microenvironment

and the peripheral circulation.

Main objective

The main objective of this study was to test three predictions of the operating
hypothesis stated above. Those predictions were I) that differences in the surface
expression of the CAM (where CAM represents the cell adhesion molecules HCAM,
VLA-4 and L-selectin) would be detectable between specimens of marrow and blood;
2) that both high and low CAM expressing CD34+ cells can be functionally demonstrated
to be hematopoietic progenitors; and 3) that VLA-4 mediates adhesion ofCD34+ cells to

a fibronectin matrix, a component of the hematopoietic microenvironment.

Specific aim I

To use flow cyto

tri
.
me rrc analysIs to determine the qualitative and quantitative

differences in cell surface expression ofHCAM, VLA
myeloid progenitors residing in the marro

.
-4 and L-selectm on CD34+

.
w as opposed to those circulating in the blood

of the same individual.
I) To enable detection and differentiation of CAM expression
. on CD34+myeloid

progenitors, a flow cytometric analysis protocol was designed.
2) To enable interpretation of qualitative and quantitative differences in cell
surface CAM expression, a computer assisted analysis program was designed.

Specific aim 2

To determine if the CAM+1-CD34+ myeloid progenitor populations examined in
Specific Aim One can be functionally demonstrated to be hematopoietic progenitors
capable of establishing both short-term and long-term hematopoiesis in vitro.
1) To ensure that highly purified (>90%), viable populations ofCAM+1-CD34+
myeloid progenitors (i.e., those myeloid progenitors expressing (+) or not expressing (-)
HCAM, VLA-4, or L-selectin) from marrow and blood could be feasibly procured, a
flow cytometric single cell sorting protocol was developed.

16

2) To detennine
sorted CAM"'CD34+

the short-te

h
"
rm ematopOietIc potential of flow cytometrically
.
,
myeloid progemtors, in vitro colony forming unit assays were

utilized.
3) To detennine

the long t
h
' .
- errn ematopOletlc potential and the number of stem

cells contained within each sorted CAM+CD34+
long term culture initiating

mye

I id
01

.
'.
progenitor population,

In

vitro

cell assays were utilized.

Specific aim 3

To demonstrate
hematopoietic

that VLA-4 mediates adhesion of CD34+ cells to the

microenvironment.

I) To observe and quantitate CD34+ myeloid progenitor cell adhesion to
fibronectin,

a component

of the hematopoietic

microenvironment,

an in vitro adhesion

assay was developed.
2) To demonstrate

that the adhesion of CD34+ myeloid progenitors to fibronectin

occurs, at least in part, via the cell adhesion molecule VLA-4, monoclonal antibodies
were used to block the binding

functions of the a4 chain of the VLA-4 heterodimer to

the CS-l binding domain of fibronectin in in vitro adhesion assays.

MATERIALS AND METHODS

Patient specimens

Seven female patients, ranging in age from 28 to 61 (mean=45, median=43),
diagnosed with breast cancer with no prior history of marrow involvement, received five
days of recombinant human granulocyte-colony stimulating factor (G-CSF, Neupogen;
Amgen, Thousand Oaks, CA) at 16 ug G-CSF / kg body weight by intravenous infusion.
Peripheral blood and bone marrow were collected on day 6 ofG-CSF mobilization.
Peripheral blood and bone marrow were collected from seven normal donors (1 male,
6 females) ranging in age from 27 to 58 (mean=37, median=34) who were being
harvested for allogeneic marrow transplantation. Peripheral blood was collected
immediately prior to bone marrow harvest in all cases. Informed consent was obtained
from each subject according to the guidelines and with the approval of the University of
South Florida Institutional Review Board.
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Preparation

of nucleated

Preparation

marrow or peripheral blood cells

of human mononuclear

blood was adapted f

peripheral

cell populations from bone marrow and

rom a protocol developed by Boyum in the late 1960's

based on principles of density gradient centrifugation
(20 mL) and peripheral
heparinized

with Dulbecco' s phosphate

respectively.

Each sample was diluted [1:1]

buffered salt solution without calcium and magnesium

(DPBS, pH=7.0; Mediatech,
density=I.113±0.001

Herndon, VA), layered onto Polymorphprep (pH=6.8±0.5,

g/mL, osmolarity 460±15 mOsm; NYCOMED PHARMA AS,

Oslo, Norway) at 20 mL diluted sample: 10 mL Polymorphprep

g for 30 minutes at room temperature
cell fractions were collected
centrifugation
activated

(RT).

and centrifuged at 500 x

The mononuclear and polymorphonuclear

and washed with DPBS by resuspension and subsequent

at 615 x g for 5 minutes at RT. The cells were washed in magnetic

cell sorting (MACS)

Novabiochem

Corporation,

an automated

hematology

Ltd., Kobe, Japan).
.
cell suspension

1)45,46Bone marrow

17 mL) samples were collected into

blood (approximately

syringes and evacuated tubes,

(APPENDIX

Buffer (MB;[0.5%

bovine serum albumin (Calbiochem-

La Jolla, CA) in DPBSJ). Cell counts were determined using
analyzer (Sysmex K-1000; TOA Medical Electronics Co.,

Follow-up

cell counts and determination of viable cells present in a

-'" rrned using a hemacytometer
were perro

in conjunction with the trypan

.
II . bilit 47,48 The trypan blue dye exclusion test is based on
blue exclusion assay of ce via I I y.
.
' tact cell membranes that exclude certain dyes, such
the principle that live cells possess In
.
'di
whereas dead cell do not In this test, a cell
as trypan blue, eosm, or propr rum,
19

suspension

is simply mixed with trypan blue and then visually examined to determine

whether cells take up or exclude dye. A clear cytoplasm would indicate a viable cell
whereas a blue cytoplasm

would indicate a nonviable cell. Thus, a cell suspension was

diluted [1:1] with trypan blue stain (0.4% trypan blue in 0.85% saline, membrane
filtered, pH=7.0, osmolarity

290±340 mOsm; GibcoBRL, Life Technologies, Inc. Grand

Island, N. Y). Ten microliters
hemacytometer.

of stained cell suspension were pipeted onto a

The hemacytometer

was placed onto the stage of binocular microscope

and the number of viable (clear, unstained) cells and nonviable (blue stained) cells were
microscopically
determined

enumerated

per 10 grids. The concentration of the cell suspension was

from the following

[Cells/mL ]=(

equation:

total cell s counted _\ x (dilution factor) x 10"
number grids counted!

The percentage of viable cells was obtained from the following equation:
% Viable cells = (
Yiable cells.
Viable cells + Nonviable

) x (I00).
cells

Cells were collected before and after centrifugation,
Leukostat

(Fisher Scientific,

Pittsburgh, PA) for morphological confirmation of density

gradient enrichment of leukocytes

Preparation

mounted onto slides and stained with

(Figures 2 and 3.)

of nucleated peripheral blood buffy coat cells

. h al blood was collected into bags containing 63 mL
Normal human penp er
anticoagulant

citrate phosphate

dextrose so

lution (USP for collection of 450 mL blood,
20

.

A.

B.

Figure 2.

Morphological confinuation of density gradient leukocyte enrichment of blood
specimen. Density gradient centrifugation of blood specimens was performed
using Ficoll-Paque Plus in order to enrich for leukocytes. Cells were collected
(A) before centrifugation (magnification 683X; bar = 15 um) and (B) after
centrifugation (magnification 597X; bar = 17 urn), mounted onto slides and
stained with Leukostat.

A.

B.

Figu re 3. Morphological confirmation of density gradient leukocyte enrichment of marrow

specimen. Density gradient centrifugation of marrow specimens was performed
using Polymorphprep in order to enrich for leukocytes. Cells were collected (A)
before and (B) after centrifugation, mounted onto slides and stained with
Leukostat. Magnification = 683X. Bar = 15 urn

22

Appendix

2) After COllection, the product was combined with 2.2 g dextrose USP
,

900 mg NaCl, 750 mg mannitol
enriched

for leukocytes

USP, 27 mg adenine USP and 154 mEq sodium and

via centrifugation
.

Of th I k
.
.
e eu ocyte ennched fraction (also

termed buffy coat), 50 uL was diluted [l:1] with DPBS for preparation of human
mononuclear

cell populations

onto Ficoll-Paque®
Pharmacia

as previously described46

Plus (pH=74,

Biotech AB, Uppsala,

Paque® Plus] and centrifuged
preferentially
separation

densitY=l.077±O.OOI

Diluted buffy coat was layered
g/ml., osmolarity=300mOsm;

Sweden) at [25 mL diluted buffy coat:lO mL Ficoll-

at 500 x g for 30 minutes at RT. Buffy coats were

enriched for leukocytes using Ficoll-Paque®

using Polymorphprep

Plus because leukocyte

(as described above for use with whole blood or marrow

samples) did not result in formation of a buffy coat layer after centrifugation.
nucleated

cell fraction was collected and resuspended

the clogging of the Miltenyi
the nucleated

The

in DPBS. In order to circumvent

columns due to platelet activation,

the platelet content of

cell fraction was reduced to s [100 x 106 platelets/mL] via a minimum of

three successive platelet reducing centrifugations

at 200 x g for 8 minutes at RT using

DPBS as the wash buffer after each centrifugation;"

Enrichment

for CD34+ cells

Mononuclear

b IT
at samples and bone marrow
cells from peripheral bloo d , u y co

were ennc. h e d f,0 r CD34+ hematopoietic
Kit (Miltenyi

.
progenitor

Biotec, Au b urn, CA , Figure 4).
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.
MACS CD34 Isolation
cells usmg a

The MACS CD34 progenitor cell

Sample layered onto density gradient

.�

500Xg

o
o

.-

Iii

~

Plasma layer (Platelets)
Burry coat layer (Leukocytes)
Gradient and erythrocyte layer

.-

Buffy coat cells labelled with anti-CD34 paramagnetic bead conjugate

Labelled cell suspension layered onto Miltenyi column
~

?
~

CD34+ cell depleted fraction
~

Magnet removed

~

~

CD34+ cell enriched fraction

Figure 4.

Enrichment of CD34+ cells from marro

24

b

w

or blood samples.

I b Ii
a e mg system for the isolation of CD34+

isolation kit is an indirect magnetic
hematopoietic

progenitor

II

cells from a stem
ce

SOurce (marrow, blood, cord blood, etc.)

by po itive selection of CD34 expressing cells M
I
. ononuc ear cells from a stem cell
source, obtained by density gradient centrifugation
Polymorphprep

(as previously

hapten-conjugated

primary

described),

monoclonal

coupled to MACS MicroBeads.

In accordance
protocol, mononuclear
in MAC

cells from marrow, peripheral

incubated with 100 ul, Reagent

blood or buffy coats were washed

at 615 x g for 5 minutes at RT.

hematology

in

Cell counts were

analyzer (Sysmex K-1000).

Cells were

Al (Fe receptor blocking reagent; human

per 1 x 10· total cells for 5 minutes at 4 DC. One hundred microliters

of Reagent A2 (hapten-modified

QBENDIO mAb which recognizes CD34)49 per I x 10·

total cells was added and incubation
Cells were washed
minutes at RT.

cell isolation kit recommended

bovine serum albumin (Calbiochem-Novabiochem)

using an automated

immunoglobulin)

labelled cells are enriched on positive

field of the MiniMACs or VarioMACS column.

DPBS at pH 7.4]) via centrifugation
determined

antibody and an anti-hapten secondary antibody

with the MACS CD34 progenitor

Buffer (MB;[O.5%

Plus or

are indirectly magnetically labelled using a

The magnetically

selection columns in the magnetic

using Ficoll-Paque®

D
was carried out for an additional 15 minutes at 4 C.

. 2.5 rnL MB per I x 10· total cells and centrifuged at 615 x g for 5

In

. 400

The pellet was resuspended

(colloidal super-paramagnetIc

_.

hapten of Reagent A2; personal

mlcrobeads
com

In

bo

/l

L MB and 100 ul, Reagent B

und to antibody which recognizes the

munication

with Kevin Mills, Ph.D., Miltenyi

.
ed at 4 DCfor 15 minutes. Cells were
Biotec)>>S2 per I x I a· total cells and incubat
25

washed with MS, resuspended in MB at 500
ul. per I x 108 total cells and filtered
through a 30 urn nylon mesh pre-separation filter (prewashed with 1.0 mL MB;
Miltenyi Biotec). The type of positive selection col

h
umn c osen for CD34' hematopoietic
progenitor cell enrichment depended on the
b
f
num er 0 total unseparated nucleated cells
obtained after density centrifugation.

The Mini-MAC

maximum cellular capacity of 2 x 108 total cells was
S

S.
separation

.
Column WItha

d h
h
.
use w en t e sample contained

2 x 10' total unseparated, nucleated cells (determined using an automated hematology

analyzer after density gradient centrifugation as previously described; Sysmex K-IOOO).
The VS' Vario-MACs Separation Column with a maximum cellular capacity of2 x 10'
total cells was used when the sample contained s 2 x 10' total nucleated cells (based on
cell counts using an automated hematology analyzer; Sysmex K-IOOO). The Mini-MACS
column was prewashed with 1.0 mL MB while the VS+Vario-MACs Separation Column
was prewashed with 3.0 mL MB in the presence of a magnet prior to addition of
microbead labelled sample. Unbound cells were eluted by washing the column three
times with 0.5 mL MB (Mini-MACS Separation Column) or with I mL MB
(VS+Vario-MACs Separation Column) and were discarded (listed as CD34' cell depleted
fraction in Figure 4). The bound cells (CD34+ cell enriched fraction) were collected by
. 1 mL (Mini-MACS Separation Column) or
removing the magnet and gently pushing
.

I

5 mL MB (VS+ Vario-MACs SeparatIOn Co umn

)th

rou

gh the column with a syringe

.
CSF mobilized marrow and blood contained
plunger. CD34+ cell enriched fractIons ofG32±18% and 17±15% [mean ± 2 x standard err

or of mean (s.e.m.) %] CD34+cells,

.
ometric analysis (next section). Normal donor
respectively, as determmed by flow cyt
26

marrow and blood MAC positive
.e.m.%)

section).

fracti
.
Ions contamed

D34+ cells res
.
,
pectlvely,

57±IZo/,
0

as determined

d 3
an

?±16% (mean±2 x

b

Y flow cytometric analysis (next
P ooled normal buffy coat positive fracn
.
actions contamed 48±5%
x s.e.m.%) CD34+ cells C II
. e counts were perf orme d usi
using an automated

(m

hemat logy analyzer

(S ysrnex K-IOOO) or hema

cytometer as previously described

arnples of blood and marrow before and after CD34+ ell'

h
.
e ennc ment were mounted

onto

lides and stained with L

k
eu ostat as previously

of Miltenyi col umn mye IOld
. progenitor

confirmation

marrow samples (Figures

described, for morphological
cell enrichment of blood and

5 and 6, Appendix 3).

Flow cytornetric analysis

Flow cytometry

employs

instrumentation

excitation sources in a liquid medium."
multiparameter
fluorescent

subpopulations

This technology

provides rapid, quantitative,

analyses on single living (or dead) cells. Measurement of visible and

light emissions

characteristics

that scans single cells flowing past

of individual

allows quantitation
cells.

of antigenic, biochemical and biophysical

Flow cytometric

technology can also separate distinct

of cells on the basis of these measured characteristics,

electronic cell sorting discussed

in the following

involve three distinct, interdependent

cell staining with fluorescent

a technology called

section. Flow cytometry experiments

phases (1) reagent preparation, cell preparation and

reagents (fluorochrome

conjugated mAbs); (2) processing

the labelled cells with the flow cytometer and data collection of one or more parameter;
27

A.

B.

Figure 5. Morphological confinuation of Miltenyi column enrichment of blood derived
myeloid progenitor cells. Leukocyte enriched blood specimens were labelled with
an anti-CD34 paramagnetic bead conjugate and enriched for CD34+ cells using
MACS. Cells from fractions either (A) depleted ofCD34+ cells (magnification
608X; bar = 16 f!m) or (B) enriched for CD34+ cells (magnification 683X; bar =
15 urn) were mounted onto slides and stained with Leukostat (Figure 4).
28

A.

B.

Figu re 6. Morphological confinnation of Miltenyi column enrichment of marrow derived
myeloid progenitor cells. Leukocyte enriched marrow specimens were labelled
with an anti-C034 paramagnetic bead conjugate and enriched for C034+ cells
using MACS Cells from each column fraction either (A) depleted of C034+
cells (magnification 512X; bar = 20 urn) or (B) enriched for C034+ cells
(magnification 598X; bar = 17 urn) were mounted onto slides and stained with
Leukostat (Figure 4).
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and ( ) computer assisted analysis of flow c
FA

_
ytometncally acquired data

lib
a I er flow cytometers (both from Becton D- .

.

FACS
can and

ickinson Immunocytometry Systems

an Jo e,

(

.

A; BDIS) utilize single air-cool d.
e argon lasers which emit light at 488

turquoise).

'
~

When a single fluorochrome labelled cell fl
ows past the argon laser each

fluor chrome emits distinct, distinguishable peak
flu r cein isothiocyanate at 525 nm (FITC

-emISSIOnwavelengths as follows:

, green), phycoerythrin at 575 nm (PE;

orange-red), and peridinin chlorophyll protein above 650 nm (PerCP; red; Figure 7)'3.'.
The peak emission wavelengths for eac h 0f t h e fl uorochromes is sufficiently far enough
apart that each signal can be detected by separate detectors. Thus fluorescent signal may

be regarded as proportional to the amount of mAb attached to the antigenic determinants
of the analyzed cell.
Samples of 1 x 106 CD34+ cell enriched fractions or 50 ~L Quantum Simply
Cellular (QSC) Beads (2 X 10· QSC beads/mL; Flow Cytometry Standards Corporation,
San Juan, PR) were labelled with three different fluorochrome-conjugated mAbs (flow
cytornetric fluorochrome conjugated mAb labelling summarized in Appendix 4).

The

samples were incubated with mAbs from Becton Dickinson Immunocytometry Systems
(BDIS; San Jose, CA) unless otherwise noted. Samples were incubated for 30 minutes at
4 °C protected from light with 20 ~L PE-conjugated anti-CD34 mAb (anti.HPCA-2),
10

J.LL

PerCP-conjugated anti-CD45 (anti-HLe-l; an antigen present on all hematopoietic

cells) and one of the following FlTC-conjugated mAbs: 20 ~Lanti-CD44
(anti_HCAMIanti-Leu-44),
Imrnunotech,

40 ~L anti-CD49d (anti-a4 chainofVLA-4 complex;

Westbrook:, ME) , or

20 OILanti-CD62L (anti-L-selectinl anti-Leu-8).
e-
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o
o
111

~
co:
~

mouse mAbs to i

I orype-identical
Immunotech;

I

rrre evant antige

IgGI-FITC

ns served as controls (IgG2a-FITC

and IgGI-PE).
Anti-CD29

Immunotech)
heterodimer).

served as a control f
.
or recogmtion
Analysis of CD49d and CD29

there was no significant
that our measurements
R

difference

incubation

of the integrin VLA-4 (an a4131

..
expresSion

In our

samples revealed that

VLA 4 d
..
- an not an umdentlfied a4 integrin.

were lysed and the

at BOIS's recommended

cells/2 mL FACSTM Lysing

'
I
mp ex;

(p>O 05) b tw
.
e een marrow or blood, thus confirming

of CD49d represented

idual red blood cells (RECs)

(anti-Bl chain of VLA-4 co

concentrations

tib d
d
an ioocy-coate
cells fixed by
of [I x 106 CD34+ enriched

Solution (BDIS)] or [I x 105 QSC beads/ 2 mL FACS Lysing

elution for 10 minutes at RT protected from light. RBC lysis involves the preferential
lysis of RBCs by the use of a hypotonic solution (FACSTM Lysing Solution) which leaves
the more robust polymorphonuclear
leukocytes by about a thousand
20,000 mononuclear
practical.
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and mononuclear

to one in the peripheral circulation; thus, the aquisition of

events without removal of RBCs would not be technologically

After two washes with OPBS, the pellets were resuspended in 200 ul, of

DPBS and analyzed on a FACScan
electronic distinction

between

.

.

flow cytometer

(BOIS). Fluorescence compensation,

the peak emission of each fluorochrome,

was adjusted

anti-CD 14-FITC or anti-CD 14-PE (BDlS) and an

using cells labelled with either
appropriate

cells intact. RBCs outnumber

I

isotype-rdentica contro

I (I G I FITC and IgG I-PE respectively;
g
,

.
d· 4) 54 Levels of fluorescence intensity considered positive
BOl )(FIgure 8 and Appen IX .

.

..

f m unlabelled cells (autofluorescence) or from

were set at regions above emISSIOns ro

..

cells labelled with an appropriate

id ntical control (nonspecific mAb binding;

Isotype-I e
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Fi ure 8. Fluorescence compensation.
Cell populations (circles) whose emmissions
spectra overlaps with another fluorochrome may be compensated (ie, false
positive events removed) by directing the flow cytometer to discard
fluorescence signal sensed in the inappropriate channeL When compensating
between FL I and FL2 channels, true FL1+ events whose emissions spectra
overlaps into the FLZ channel (e) may be compensated (e) by adjusting
flow cytometric parameters f-+); unlabelled cells (0) are detected as
negative events in both channels. Compensation between FL2 and FL3
channels (B) is performed as with FLIIFL2 compensation.
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•

•

tl,

Figure 8). Autofluorescence
can
'.
occur when cellular constituents absorb ener a
.
light when Illuminated by las
li h
gy nd emil
er Ig t. Nonspecific mAb bi di
in mg can occur when Fe

recept

present on the cell membrane

bind the Fe

.
portIOn of mAbs used for labelling

orward

caner (FSC) events

were collected

0

nd flu re cence channel (FL I, FL2 and FL3)
mode til

of 10,000 events per sample tub

conjunction

with the F ACStar and FACS

conjunction

with the F ACSCaliber

BD! ). Data files were analyzed

li
.
n a mear scale, while side scatter (SSC)

events were collected on a log scale. List

'.
e were acquired using Lysis II software in

can

fl

ow cytometers or using CELLQuest in

flow cytometer

(all programs and instruments by

offline using WinList software (Verity Software House,

Top ham, ME)
The individual

cell types in each sample were differentiated using a method

imilar to the one originally

reported by Stelzer et al. 57 Analysis of SSC and CD45

fluorescence

(CD45 is expressed

hematopoietic

tissues) allowed

of cell types including
myeloid progenitors
corresponding

F

tar

(consult

on all human leukocytes but absent from nondifferentiation

lymphocytes,

and lymphoid

monocytes,
progenitors

to SSC and CD45 fluorescence

or FACSCaliber
low cytometric

of marrow and blood into distinct regions
immature and mature granulocytes,
(Figure 9).'7.58 Individual cell types,
cell type regions, were sorted using a

flow cytometer (BDIS) from samples of marrow and blood
single cell sorting section). Microscope slides were prepared of

.
.f
d counterstained with Leukostat
each sorted cell type region using a cytocentn uge an
(Fisher

..'
cientific; FIgures

confirmation

lOan

of the morphologic

d I I)

.

L

eu

kocyte differentials of prepared slides enabled

characteristics
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of sorted cell type regions. Leukocyte
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Side Scatter Fluorescence
igure 9. Flow cytomctric analysis of side scatter and CD45 fluorescence. Bloodand
marrow samples enriched for CD34+ cells were flow cytometrically
differentiated into lymphocytes, monocytes, granulocytes, lymphoid
progenitors and myeloid progenitors (gray) based on side scatter and CD45
fluorescence.
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A.

B.

Figu re 10. Morphological confinnation of sorted lymphocytes and monocytes. Marrow
specimens were enriched for CD34+ cells and flow cytometrically sorted using
side scatter and CD45 fluorescence based regions. Cells sorted based on the
(A) lymphocyte region (magnification = 598X; bar = 17 urn) and the (B)
monocyte region (magnification = 683X; bar = 15 urn) were collected, mounted
onto slides and stained with Leukostat.
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A.

.,
B.

Figure 11.

Morphological confinnation of sorted grannlocytes and myeloid progenitors.
Marrow specimens were enriched for CD34+ cells and flow cytometrically sorted
using side scatter and CD45 fluorescence based regions. Cells sorted based on
the (A) immature and mature granulocyte region (magnification = 598X; bar =
17 urn) and the (B) myeloid progenitor region (magnification = 683X; bar =
15 urn) were collected, mounted onto slides and stained with Leukostat.
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.
ki dl erformed by Dr. Sean Farrier, a senior hematology resident
differenualswere n y p
.
f his findings by Dr. Lynn Moscinski
withconfirmatlon 0 I

Standard leukocyte

.
.f
d slide preparations include I) scanning the entire slide to
differenUalof cytocentn uge
.
ntative field to count and 2) enumeration of specific cell types
detennme the most represe
until 100 total cells have been counted (2-4 fields are counted depending on the density
of cellsin the preparation, personal communication with Dr. Sean Farrier). A typical
leukocytedifferential of sorted cell type regions is listed in Table One.
The number of CD34+ cells in the myeloid progenitor population was determined
by subtractingthe PE false positive events of the isotype control from the CD34 + events
inthemyeloid progenitor gated population of each specimen. The percentage of CD34 +
cellswithin each sample was determined by dividing the total number of CD34+ cells by
thetotal number of cellular events as gated on SSC and CD45 fluorescence based regions
in eachspecimen (Figures 9 and 12). The percentage ofCD34+ cells within the myeloid
progenitorpopulation of each specimen was determined by dividing the number of
CD34'events in the myeloid progenitor gated population by the total number of events
inthemyeloid progenitor gated population. The total number of CAM+CD34+ cells in
themyeloidprogenitor population was determined by subtracting the FITC/PE false
positiveevents of the isotype control from the number ofCAM+CD34+ events in the
myeloidprogenitor

t d
I'
f
.
ga e popu anon 0 each specimen. The percentage of CAM+ cells in

theCD34+my I id
.
e 01 progemtor population was determined by dividing the number of
CAM'CD34'
eventsin the

.
events III the myeloid progenitor gated population by the number of CD34+

I' d
mye 01 progenitor gated population.
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The mean channel fluorescence for

_bl One. Leukocyte differential of sorted cell type regions. On the basis of side scatter versus CD45
Iluo
nee individual lymphocyte., monocyte., granulocyte. and myeloid progenitors were now
110m IMeally sorted according to cell type region. described by Stelzer et al." Leukocyte differentials
Leuko tat stained slides of now cytometrically sorted cell type region. are Iiated as a percentage of
100
II i.!
wunted
m.lr row
shown per slide. Leukocyte differential of a representative .orting experiment of normal

r

Cell Type Region Sorted
(Based on Side Scatter versus CD45 Fluorescence)

ell Type Observed
Myelobla

Lymphocytes

Monocytes

Mature &
Immature
Granulocvtes

t

Myeloid
Progenitors
52

Promyelocyte
Myelocyte, neutrophilic

3

30

3

7

2

tamyelocyte,
n utrophilic

1

15

B nd neutrophil

1

20

Segmented

5

51

neutrophil

2

Eo inophils (including
young forms)
Basophils (including
young forms)
onocytes
Lymphocytes

100

90

3

3

3

6
3

PIa macytes
Pronormoblasts
&
Ba ophilic normoblasts
Polychromatic
normoblasts and
Orthochromatic
normoblasts
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CAM Fluorescence
CD34+ myeloid progenitor (gated)
Figure 12.

10(1)

H Based on isotype identical controls

Flow cytometric analysis of cell adhesion molecule expression on CD34+
myeloid progenitors Samples enriched for CD34+ cells were labelled with
mAbs against C034, CD45 and one of the CAMs under investigation.
Myeloid progenitors were distinguished from all events (A) on the basis of side
scatter and CD45 fluorescence and gated (Figure 9). Gated myeloid progenitor
events (B) were then analyzed on the basis of CAM and C034 fluorescencein
order to determine the percentage of C034+ myeloid progenitors coexpressing
CAMs. Gated C034+ myeloid progenitor cells (gray) were analyzed to
determine their peak channel fluorescence such that CAM expression per
CD34+ myeloid progenitor could be quantitated. Analysis of marrowderived
HCAM+C034+ myeloid progenitors is depicted.
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each LJo\IVI_FITC conjugate
determined
progenitor

I'
m ye Old progenitor Population was
the n
b
.
urn er of Abc umts per CD34+ myeloid

within the CD34+

and used to extrapolate
as described

of Q

in the following section.

beads to quantitate

number of antibodies bound per cell

beads were provided

from the manufacturer

in a mixture of five types of

bead • each with a defined number of antibody binding sites or antibody binding capacity
( be) units per bead.
were labelled;

The QSC bead mixture was labelled and analyzed just as the cells

that is, using the same isotype and quantity of mAb, incubation conditions,

wash conditions

and acquistion

conditions used to label the blood and marrow samples.

The mean peak channel fluorescence

for each of the five beads was determined

(Figure 13) and plotted against the each QSC bead's Abc units or against the natural log
In) of each QSC bead's Abc units (Figure 14). Linear regression analysis of these
standard curves generated
myeloid progenitor

a best fit line from which

the number of Abc units per CD34+

cells from blood or marrow was determined (Figure 14). Analysis

and graphics of standard curves of peak channel fluorescence versus antibody binding
.
. Lotus 1-2-3 version 4 (Lotus Development
capacity were created for each antibody usmg
Corporation,

Cambridge,

MA) .
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Fluorescence intensity
Figu re 13.

Determination of mean peak channel fluorescence of QSC bead standards.
umber of binding sites per QSC bead: 1=0; 11=6,841;11I=16,438;
IV=51,927 and V=81, 191 Representative experiment depicted.
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Flov

C

ometric single cell Sorting

.

II processing of blood and m arrow samples was p rf
.
e onned In a sterile manner in

u n for sterile sorting and subseq uen t fIn vitro
.
assays . P'nor to sterile
. sorting with
aliber flow cytometer, the instrument was thoroughly washed with sterile
filtered 700/0 ethanol. Each of the samples to be ana I yzed were collected as data files' on

the fl w cyt meter (described in the flow cytometric anaI'
ion) . Random sort
YSlSsection

were drawn, sterile filtered 70% ethanol was placed on the samp I"e mjection
. port

t

IP , the sheath fluid reservoir was replaced with a reservoir containing sterile filtered
70% ethanol and three sterile 50 mL conical tubes tubes were placed onto the collection
tub pons. The instrument was directed to sort until each of the three collection tubes
had filled to approximately 37 rnL per tube, which took approximately 9 minutes per
collection tube. The collection tubes containing 70% ethanol were discarded and
replaced with three additional sterile 50 rnL conical tubes. The reservoir containing 70%
ethanol was replaced with a reservoir containing sterile, filtered phosphate puffer
(pH 7.4; Appendix 5) and sterile DPBS was placed onto the SIP. The instrument was

directed to sort until each of the three collection tubes had filled to approximately 37 mL
per tube, as described above. Once the F ACSCaliber had been sterilized in this manner,
the sort sample was placed onto the SIP. Aquisition of the sort sample on FSC versus

S

fluorescence enabled region 1 to be drawn about small, viable, single myeloid

dle
progenitor cells within the marroW or b I00 samp
.
00

light scatter patterns

di

Ictate

(Figure 15) This region was based
.

d b SSC versus CD45 fluorescence as previously
y
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Scatter

Fi ure 1 . flow cytometric sorting regions and gales. Pooled buffy coat samples were
enriched for CD34+ cells and labelled with fluorochrome conjugated mAbs for
flow cytometric analysis and single cell sorting. Labelled cells were analyzed on
the basis of side scatter and CD34 expression. Small CD34+ cells (Region I)
were gated and analYzed on the basis of forward scatter versus side scatter such
that Region 2 could be drawn around myeloid progenitors. Region 2 was gated
and analyzed on the basis of CAM versus CD34 fluorescence such that Region 3
could be drawn around CAM+CD34+ events. The flow cytometer was directed
to sort only those events which satisfied the criteria of Region 2 (myeloid
progenitors of low cellular complexity) and Region 3 (cells expressing both
CAM and CD34).
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d cribed (Figure 9)
rcquir

The logic of the FACSCalib

fl
er ow cytometer sorting software

that the fir t region in th

.
e sort gatmg be based on FSe versus sse fl
uorescence.
In rd t determine where the
..
.
.
region inclusive of target cells (CAM+I-CD34+ myeloid

pro enu rs) hould be drawn in FSC versus SSC fl
10 In

uorescence plots, Region 1 was drawn

lude viable single CD34'
loid
.
,
mye 01 progellitor cells on the basis of SSC versus

D 4 f1 r cenee. Region I was gated and analyzed on the basis ofFSC versus SSC
such th t region 2 could be drawn around myeloid progenitors. Region 2 was gated and
anal zed

n the basis of CAM (HCAM, VLA-4 or L-selectin) versus CD34 fluorescence

such that Region 3 could be drawn around CAM+CD34+ events (Figure 15). The flow
cytometer was then directed to sort only those events which satisfied the criteria of
Re ion 2 (myeloid progenitors of low cellular complexity) and Region 3 (cells
expressing both CAM and CD34; Figure 15). The target cells were sorted at a threshold
rate of approximately 1500 events per second and a sort rate of approximately 15 events
per econd. The FACSCaliber possesses the following three distinct sort modes: single
cell, recovery and exclusion (Figure 16). The sort mode with the highest purity of
recovered cells is the single cell mode followed by the exclusion and recovery modes,
respectively.

The sort mode with the highest yield (but lowest purity) is the recovery

mode, followed by the exclusion and single cell modes, respectively. By sacrificing
f th highest post sort purities possible, the single cell mode was
e
. d
Th se sorting parameters enabled the
used for all sterile, FACSCaliber assiste sorts.
e
recovery

. th

In

.
e pursuit

0

.
II to be sorted in the minimum amount of time (on
maximum number of target ce s
I . was performed by flow cytometrically
average 60 minutes per sort). Post-sort ana YSIS
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t'l

}

no sort

}no

}

no sort

sort
"
')

'\

ingJ

ell Mode

Recovery Mode

Exclusion

I
I

I

I II

Sort envelope

•

Target cell

o

"

Nontarget cell

;gore 16. How envelopes were sorted for each sort mode. In Single Cell Mode, a
sort occurred whenever a single target cell was identified in the sort
envelope. Envelopes containing more than one cell, even if a target cell,
were not sorted. In Recovery Mode, a sort occurred whenever a sort
envelope contained a tuget ceIl, even if a nontarget cell was also in the
envelope or a target cell was just outside the sort envelope. In Exclusion
Mode, a sort occurred only when a target cell was identified within the
defined sort envelope, no attempts were made to capture target cells
outside the sort envelope.
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zing 200~L of sorted sample
.
pnor to further process in .
I
) If
g (i.e., performance of CFU
r

ay.

a post-sort

purity of ;:.900/.

•

0

processing of the specimen
.

nd
.

was abort d M'
e.
tcroscope slides were prepared of pre-sort

t-s rt pecrmens (CD34+ ennched
.
fraction and CAM+CD34+ or CAMCD34+

m el id progenitors,

respectively)

i her

di

of prepared

rential

usin g a c ytocentnfuge
.

and counterstained with

cientiJ fiIC ) as previously
.
described (Figure 17). Leukocyte

Leuxosta:

pe

was not obtained, then further

slides enabled con fiirmauon
. of post-sort purities (kindly

rmed by Dr . Sean F'arrier as previously
.

o pr - and po t- ort CAM+1-CD34+

mye I'd
OJ

described). A typical leukocyte differential
progenitor is listed in Table Two.

..
:1
"

I ny forming unit assay

,

,I
To assess short-term

hematopoietic

II
"

potential, sorted CAM+CD34+ myeloid
J

progenitor

cells from normal marrow or pooled buffy coats were plated in triplicate into

35mm2 petri dishes containing

1 mL MethocultlMH4434

Technologies

B.C., Canada). Methocult is a "complete" methlycellulose

medium

lnc., Vancouver,

containing

recombinant

human cells [0.9% methylcellulose,
I<J' M 2-mercaptoethanol,
rh GM-CSF

per dish (Methocult; StemCell

human (rh) cytokines necessary for colony assays of
30% fetal bovine serum, 1% bovine serum albumin,

2 mM L_glutarnine,

50 ng/mL rh stem cell factor, 10 ng/ml,

and 10 nglmL IL-3, 3 units/mL

rh erythropoietin in 70% lscove's DMEM]

1 mL of cell suspension

[500 sorted cells in 0.1 mL Iscove's media

Each dish received

(Mediatech)/mL
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,I

"

A.

c.

B.

'I

I
"

igure 17.

Morphological

confirmation

of myeloid progenitor sort purity. (A) Samples

were enriched for CD34+ cells using MACS (magnification 683X; bar = 15

um). (B) CD34+ myeloid progenitors expressing (magnification 640X, bar =
16 urn) or (C) not expressing (magnification 512X; bar = 20 I'm) the cell
adhesion molecule of interest were flow cytometrically sorted. Sort of
VLA-4+CD34+ myeloid progenitors derived from marrow shown.
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!

bk
o. Leukocyte differential of pre- and post-sort CD34+ myeloid progenitor cell preparations.
ul< y'f diff renUals of Leukostat stained slides of CD34+ ceOenricbed fraction (pre-sort) and flow
rlorn I
lIy sorted CAM+<'CD34+ myeloid progenitors (po,t-,ort) Were reported as a percentage of
unted per slid e, A leUkocyte differential of a single ceO sort from marrow targeted at
It bijtbly' purined posl-sort specimens ofVLA-4+CD34+ and VLA-4"CD34+ myeloid progeniton
MpreUD~t d.

Pre-Sort
II ype Observed

. Myelobla

I

t

Post-Sort

CD34+ Cell
Enriched
Fraction

VLA-4+CD34+
Myeloid
Progenitors

VLA-4"CD34+
Myeloid
Progenitors

2

98

69

PI" m.!elocyte

4

15

Myelocyte,

6

3

neutrophilic

t myelocyte,

neutrophilic

9

Band n utrophil

13

"

Segm

50

'I

nted neutrophil

o inophils
form)

B ophil
form)

(including

young

,

1

J
(including

young

J

1,1

onocytes

5

Lymphocytes

6

3
2

PLa.smacytes
Pronormo bl as ts & Basophilic
normoblasts

2

Pol chromatic . nor. moblasts
and Orthochromatic
normoblasts

2
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10

"

A

Methocultj.

fter 14 days of incubation at 37°C in a humidified atmosphere of 5%

ill'

CO,:95% air, colonies were scored and typed as CFU-E, BFU-E, CFU-GM and
CFU-mix based on an atlas of human hematopoietic colonies developed by Eaves et al.
(Figures 18 and 19).59
Using the culture conditions outlined above, progenitors differentiate as they
divid with the result that after a finite and predictable incubation (i.e. 14 days) all cells
will have reached maturity and the colony will not increase in size any further.

S9

This

feature of colony development allowed different stages of progenitor development to be
distinguished according to the sizes of colony they ultimately generated.

Thus the bigger

the colony, the greater the proliferative capacity and the more primitive the original
progenitor from which it arose. S9
CFU-E refers to those colonies which give rise to the smallest (less than 0.5 mm),
most rapidly maturing erythroid colonies."

In the context of the CFU assays presented

herein, a colony was scored as a CFU-E colony 1) when it consisted of 1-2 clusters
containing up to a maximum of -100-200 erythroblasts and 2) when each cluster
contained a minimum of 8 erytbroblasts (Figure 18A). Erythroblasts

are readily

discernible in methycellulose by their distinct reddish-orange hue due to their
hemoglobin content (Figure 18A).s9
BFU-E refers to the immediate precursors ofCFU-E .S9

I n or d er c.ror a colony to

be scored as a BFU -E , It
. h a d to contain at least 3 erythroblast clusters with each I
custer
consisting of -100 - SOOhemozlobi
.
emog obinized
erythroblasts or a single colony >0 5
..
. rnm III size
usually presenting with a "fried egg" morp holozv
ff'i
0 ogy (FIgure 18B)59
51

'

A.

1

,
,

,

'.

igure 18.

Microscopic characteristics ofCFU-E and BFU-E colony types. Sorted
CAM+/-CD34+ myeloid progenitors were plated into colony fonning units 59
assays. Colonies were scored according to standards set forth by Eaves et a1
as (A) CFU-E colonies (magnification 68X) or (B) BFU-E colonies
(magnification 4IX). Bar = 200 urn.
51

'.

Figur

19.

Microscopic characteristics ofCFU-GM and CFU-mix colony types. Sorted
CAM+!-CD34+ myeloid progenitors were plated into colony forming units
assays. Colonies were scored according to standards set forth by Eaves et aJ59
as (A) CFU-GM colonies (magnification 54X) or (B) CFU-mix colonies
(magnification 49X). Bar = 200 urn.
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- M

uloevres
ntained
I

and macrophages.
. .
minimum of 20 g

"

.centra ~..
n

I"...central
"

.

A colon

core of ce IIs surrounded b Y a Iess dense hal
.
00 f cells (Figure 19A) 59

-rmx colonies refer to colonies
"

ri

.

asis of their abilit t

y 0 produce colonies of
y was scored as a CFU-GM
I
colony when it
ranu ocytes and/or macro
phages (Figure 19A) 19
h wed a relatively hom
. Typically
ogenous morph I
0 ogy often with a more

ru

th

lorries we re Scored on the b

.

.

me containing

re

hi h

W IC

.
resulted from progenitor cells that gave

mull' IP Ie I'meages of cell . CFU -mrx
". colonies
. are sometimes

U-GEMM (colony forming unit-granulocyte , eryth rOI"d, macrophage,

mega..karyocyte)

to indicate the' ir mu I'tip Ie lineage
.
potential .59 CFU"-mrx colonies
. were

isunct cell lineage types could be visualized by focusing up and
red when th ree disti
d wn under high power (Figure

Preparation

19B)59

of stromal cell layers

tromal cell layers for long term culture initiating cell (LTCIC) assays were
prepared from cells trapped
from harvested

on filters designed to remove cell clumps and other debris

marrow samples.

waste) after a bone marrow

Salvage of these filters (they are normally discarded as

harvest from a normal individual donating for allogeneic

transplant enabled normal human bone marrow stromal cells to be obtained. Filters were
flushed with DPBS to collect trapped cells. To deplete the RBC content, collected cells
were layered onto Ficoll-Paque®
Plus] and centrifuged

Plus at [25 mL diluted sample: 10 mL Ficoll-Paque®

at 500 x g for 30 minutes at RT according to a modified version of
54

Boyum's method" The light density cells were washed three times with DPBS via
centrifugation at 615 x g for 5 minutes at RT. The resultant cells were admixed in
LTBMCmedium [lO-6M hydrocortisone, 12.5% horse serum (GibcoBRL) and 12.5%
fetalbovine serum (GibcoBRL) in alpha-minimum essential medium (alpha-MEM;
Mediatech)]at a final cell concentration of [106 cells/mL LTBMC media] and were
aliquoted at 5 mL per 25 em? flask to be seeded. The cultures are incubated at 33°C in a
humidifiedatmosphere of 5% CO2:95% air. After three weeks of culture with weekly
completemedium changes, the cells were trypsinized, pooled, washed, and re-plated at a
ratioof two new flasks per one original flask; thus a stromal feeder layer consisting of
normalhuman stromal cells was established.

Longterm culture initiating cell assay

Long term culture initiating cell (LTCIC) assays, developed by Sutherland et al .,
wereestablished in order to measure the number of stem cells with long term in vivo
01d progenitors
repopulatingpotential within sorted populations of CAM+CD34+ mye I·
.

(Figure20) . 13 LTCIC assays enable quantrtation
. . of human LTCIC content based on an
assessmentof the nurnb er 0 f C
clonozeni
onogernc cells present after 5-8 weeks in vitro.
Clonogeniccell out put d epends on the presence of a stromal cell feeder Iayer an d IS
.
linearly relatedto th e input
.
cell number over a wide range of cell concentrations.
.
. ..
Llmltmg dilution ana I'
YSlS of clonogenic cell output enables quantitation of L TCICs or
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Long term culture initiating cell assay.
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.
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I th
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.
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.
34 myelOId

II

p

p inized normal human stromal cell I
ayers from established L TBMC (
oreearan

n

trnma

I

s see
cell layers section)
.
on were Irradiated at 20 Gy (d estroys radiation
. .

hem t poietic stem cells while strom
well flat-b

.
al cells remain functionally intact) and

nom microtiter tra ys (Fi
Fisher Scientific) at 6 X 104 cells per

, M2-1 OB4 cells (Batch F-12495 , Am'encan T ype Culture Collection ,
) were used as the stromal cell layer . M2-IOB4 ce IIs are a munne
. bone

marrew

mal cell line capable
el

of maintain in gong
I

derived stromal layers .60 M2-IOB4 cell s were trra
. dilate d

as human marrow

ted into 96 well flat-bottom
incubated

4" myeloid

progenitor

Tb eultur
%

received

were maintained

in replicates

of 24 wells per dilution. An additional

L TBMC media alone and served as a negative control.
for five weeks at 33°C in a humidified atmosphere of
by half volume complete LTBMC media

t week five of culture, cells in each well were harvested via trypinsinization

and plated into

FU assays.
. d

b

in a humidified atmosphere of

of stromal cells. Cells to be assayed (sorted

}.9 % air with weekly demifeeding

chan -

trays at 3 X 104 cells per well. The

cells) were plated in LTBMC media in dilutions of 3,

10, 0, 100, 00 and 1000 cells/well
plate of trornal cell

microtiter

for at least 24 hrs at 33°C

% air to allow adherence
'I"

. . in vitro
term human hematopoiesis

been demonstrated

III

Since no significant

difference (p>0.05) in LTCIC content

. d LTCIC content between five and eight week
eterrnille
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•

cultur

,five weeks of culture was chos

13

en.

On day 14 of the CFU assay portion of the

as ay, wells were scored as ith
..
ei er posrtrve (colonies observable) or negative (no
b ervable colonies)
The number of stem cells present per input cell was determined using Poisson
tati ti

which states that if the average number of long term culture initiating cells

plated per well equals one, then the probability

of no positive wells is

p(O) =( (e-1)(IO)]1 01 = (l/e)(l) = lie = 0.37
u the probability

po itive wells)
T

=

of finding

~ I positive well (i.e. the probablity of not finding 0

1-0.37 = 0.63; that is, 63% of the wells plated will be positive when one

IC is plated per well.

By plotting the number of cells plated per well by the

')

'I
percentage

of positive wells, the number of cells corresponding to 63% positive wells

was interpolated

as the number of cells containing

one LTCIC (Figure 21). The number

of L TCICs per sorted cell plated was then converted to L TCIC/106 sorted cells for all

,
J

!

'.
comparative

analyses.

VLA-4 adhesion assay

The adhesion of sorted populations
immobilized

.
fibronectm

adhesion assay.,,62
immobilization

(FN) was measur

Typically

of VLA-4+CD34+ myeloid progenitors to
ed using a modified version of Shimizu et al. ' s

static adhesion assays involve five steps (I)

.'
of target ligand to microliter

we

lis (2) addition of 5lCr-labelled target
,

f activating agents, (3) initiation of adhesion by
cells at 4 DC in the presence

or absence

0
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100

80

··.

60

··
·

40

10(1)

10(2)

Sorted CAM+1- CD34 + myeloid progenitors

10(3)

plated/well

Figure 21. Determination of number LTCIC per 106 sorted CAM+I- CD34+ myeloid
progenitor cells. Myeloid progenitors were flow cytometrically sorted from
either pooled buffy coats or hematopoietically normal marrow. These highly
purified cell populations (post-sort purity >90% in all cases) were plated in
limiting dilutions ranging from 3 to 1000 cells/well (replicates of 24 per
dilution) in accordance with performance of the LTCIC assay (Figure 20).
According to Poisson statistics, the number of sorted myeloid progenitors
corresponding with 63% positive wells (i.e., wells containing at least I colony)
reflect the number of sorted myeloid progenitors containing one LTCIC. Using
the above representative experiment as an example, 63% of the wells were
positive when 19 sorted myeloid progenitor cells were plated per well. In other
words, there were 52,632 LTCIC per 106 CAM+I-CD34+ myeloid progenitor
cells sorted.
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t 37"C (4) washing away nonadherent cel1s, and
increasingtemperature
•.

01

0

,

adherent cells by lysing them and measuring "Cr y emissions.

A

(5) determmmg yo
.
.
dhesion assay was developed in which cells were labelled with a
nonradIOactivea
. gated mAb and analyzed flow cytometrically instead of using 51Cr
fluorochromeconju
.
t
The remaining steps of both assays were carried out
labellingand a scintiIIanon coun er.
in the same manner.
Prior to execution of the VLA-4 adhesion assay, the concentration ofFN per wel1,
typeof microtiter plate, and incubation duration was optimized using protocols suggested
by Mobley et al. and described in detail herein.F

Human plasma fibronectin (FN; >95%

pureby sodium dodecylsulfate polyacrylamide gel electrophoresis, mycoplasm negative
by MYCOTECTT" System and DNA staining, functional performance verified by cel1
attachmentand spreading assays using BHK-21 cel1s performed by manufacturere;
GIBCOIBRL,Grand Island, NY) was sequential1y diluted at [2 mg/ml.], [200 ug/ml.],
[20ug/ml.], [2 ug/ml.], [200 ng/mL], and [20 nglmL]. Fifty microliters of each dilution
waspipeted into seven rows of either a 96-wel1 tissue culture-treated microtiter plate
(CostarCorporation, Cambridge, MA) or a 96-wel1 ELISA-treated microtiter plate
(Nunc,Naperville, IL) with the eighth row left empty for use as negative control wel1s.
FinalFN concentrations per well were 100 ug/well, 10 ug/well, 1 ug/well, 100 ng/wel1,
lOng/well, and 1 ng/well. Plates were covered and incubated for 1 hour at R T
Unboundligand was was h e d from we II·s Via several successive
. washes with 200 ul,
PBS/HSAbuffer [PBS with Ca2+ and Mg2+, (v/v) 0.5% human serum albumin US.P,
pH~7 2 (Th

.

.

erapeunc AJpha Corporation, Los Angeles, CA)). Remaining unbound
60

2

, bi d'ng sites were blocked by incubation with PBS/BSA buffer [PBS with Ca '
proteln- In I
& Mit and 2.5% (w/v) bovine serum albumin, pH=7.2] for 2 hours at
The wells

n°c.

ith 200 OIL PBS/HSA and incubated with 50 ul, of PBS/HSA buffer;,
h
d
werewas e WI
e,
t 40C pooled buffy coat samples enriched for CD34+ hematopoietic
minutesa
'

30

progenitor

3

cellswere resuspended in PBS/HSA buffer at a concentration of [10 cells/ul-].

A small

fraction(200 flL) of CD34+ HPCs was reserved for flow cytometric analysis of viable
VLA-4+CD34+myeloid progenitor cell content as previously described, Cells were plated
intriplicate onto FN-coated and blank (not FN-coated) wel1s at 50 flLlwell (50,000
cells/well). Cell adhesion to immobilized FN was initiated by raising the temperature

to

370Cfor 10, 20, 30, 40, 50, 60, and 120 minutes or overnight in a humidified atmosphere
of 5% CO :95% air (optimization of incubation time). Nonadherent

cel1s (i.e. free in the

2

solution)were collected via three gentle successive washes with 200 ul, PBSIHSA buffer
perwell and pooled. Adherent cel1swere harvested via trypsinization

Viable

nonadherentand adherent cells per wel1 were enumerated via the trypan blue exclusion
assay. Nonadherent and adherent cel1s from each well were labelled for flow cytometric
analysisof VLA-4, CD34 and CD45 expression as previously described.
The percentage of pre-binding assay sample (original1y seeded cell preparation

of

50,000cells/well), nonadherent cells (free in solution after initiation of adhesion), and
adherentcells (boun d aft er imtianon
... . of adhesion)
.' which were viable VLA-4+CD34+
myeloidprogenitors was d etermme
. d flow cytometrically as previously described.

The

numberof viable cell S WIithi10 th e pre- biinding assay, nonadherent cel1 and adherent cel1
sampleswere quantiItat e d via
. the trypan blue exclusion assay, The absolute number of
61

.
A_4'CD34' myeloid progenitors contained within the pre-binding assay,
viableVL
d dherent cell samples was determined from the following equation:
nonadherentceII an a
.
it - (o/VLA_4+CD34+myeloidprogenitors)(O.OI)(total cells)
VLA_4'CD34+
myelOidprogem ors - /0
iabl VLA-4+CD34+ myeloid progenitors adhering to fibronectin
The percentage0f via e

was

calculatedfrom the following equation:
Vjable Adherent VI A_4+CD34+ myelojd progenito,:,

(ViableVLA-4+CD34+
myeloid progenitors (pre-adhesion assay)

% viable adherent

)

x I00 ~

VLA-4+CD34+
myeloid progenitors

The percentageof viable nonadherent VLA-4+CD34+ myeloid progenitors was calculated
fromthe following equation:
--YiBble NonadherentVI ,A-4+CD34+
myeloid progenitors
)
% viable nonadherent
( ViableVLA-4+CD34+myeloid
progenitors (pre-adhesion assay) x 100 ~
VLA-4+CD34+
myeloid progenitors
The percentageof viable nonadherent VLA-4+CD34+ myeloid progenitors was
calculatedonly during the optimization adhesion assay experiments to demonstrate the
abilityto track the location of VLA-4+CD34+ myeloid progenitors as either free in
solutionor bound to FN.
The optimal parameters determined for the adhesion assay (n=3) were as follows
FN concentrationof 1 ug/well, 96-well ELISA-treated microtiter plate (Nunc), and
incubationat 37°C for 1 hour (Figure 22), In all of the adhesion assays described
herein,the same lot of FN and NUNC plates were used to minimize alterations in
adhesiondueto batch-to-batch differences in FN or plate preparations.
FN [20 ng/ul, PBS with Ca2+ and Mg2+] was dispensed at 50 ilL/well into 96 well
plates(Nunc) .th
WI

one row of wells left empty to serve as negative controls. The plates
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..,

T Unbound FN was removed by several successive
were incubatedfor one hour at R .
. h PBS/HSA buffer. Protein-binding sites in ligand-coated wells and wells
washesWit
.'

0

recelvmgn

II'gandwere blocked by incubation with PBSIBSA buffer for 2 hours at

370C. The wells were washed with 200 JlL PBS/HSA and incubated with SO JlL of
PBS/HSAbuffer ~ 30 minutes at 4°C.

Pooled buffy coat samples were enriched for

CD34' myeloid progenitor cells (Figure 4). A small fraction of cells was reserved for
flow cytometric analysis ofVLA-4+CD34+ orCD34+ myeloid progenitor cell content as
previouslydescribed. Cells were resuspended in PBSIHSA buffer at a concentration
[10' cells/pl.].

of

Treatment groups were plated in replicates of four at SO JlLlwell (50,000

cells/well). Group one was plated onto blank, non-coated wells (served as nonspecific
bindingcontrols). All remaining groups were plated onto FN coated wells. Group two
was platedin PBS/HSA buffer alone. Group three received 6 JlLl well mAb
(anti-CD49d-FITC;lmmunotech) against the 0:4 chain of the VLA-4 a4f31 heterodimer.
Groupfour received an immunotype identical mAb (lgG2a-FITC;

Immunotech) which

doesnot bind either chain of the VLA-4 heterodimer (served as an isotype identical,
nonspecificbinding control for mAbs). Cell adhesion to the immobilized FN was
initiatedby raising
.,
th e temperature to 37°C for 60 minutes in a humidified atmosphere

of

5% CO z- 950/.0 air.
. Th e number of viable CD34+ cells not adhering to fibronectin was
determinedby the trypan blue exclusion
' assay as previously described. The number of
viableCD34+mye I'd
.
01 progemtor cells binding FN per well was dete rmine
' d as d escnbed
'
above.Adherent cell s were harvested via
' trypsinization labelled for flow cyt
,
ometnc,
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Figure 22. Optimization of adhesion assay. To determine the optimal concentration of
fibroneetin (FN), adhesion assays (n=3) of pooled buffy coat samples enriched
for C034+ cells were performed using concentrations of FN ranging from
0.001 to 10 ug FN/well (A). On average the highest percentage of
VLA-4+C034+ myeloid progenitors bound to FN concentrations> 0.0 I flg
FN/well (A). A concentration of I ~ FN/well was chosen from the plateau
phase of the graph (indicated by asterisk) for all adhesion assays. To determine
the optimal incubation time, adhesion assays (n=3) of pooled buffy coat
samples enriched for C034+ cells were performed at incubations ranging from
10 minutes to 24 hours (B). The greatest percentage ofVLA-4+C034+
myeloid progenitor cells bound after I hr of incubation (indicated by asterisk).
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an I i 0
of i bl
.

LA-4, CD34 and C045 expressIOn
.
as
dherent VLA-4' C034'

or

C

.
prevIOusly described

Th

.
e percentage
034+ my I id
e 01 progenitors was determined

d crib d ab ve.

tati ti

as

I analy

II stati tical analyses

and grap hiICSwere generated using one of the following

ftware programs, alone or in combination
'Ii indow

as dictated by th e app I"icatron: Statistica
. . for

( tatsoft, Tulsa, OK), Lotusl-2-3

or Harvard Graphics version
The following

3.0 (Software

discussion

version 4 (Lotus Development Corporation),
Publishing Corporation,

of statistical tests, their applications and assumptions

was obtained from the Statistica for Windows
application software.
for all comparative

The Student's
analyses

owner's manual supplied with the

t-test for dependent samples (paired T-test) was used

of paired marrow and blood samples. This statistic enables

the comparison of means among variables
myeloid progenitor between

(e.g. mean CAM expression per CD34'

blood and marrow) measured in the same sample (e.g. same

individual's blood and marrow).

The null hypothesis of the paired t-test states that there

is no diffeence between the meanS of the measured variable.
h ypo

thesi

esis

f th
0

Santa Clara, CA).

For example, the null

. d
and blood samples states that there is no difference
e parre marrow

.
etween
e
mean
expresSIOn
b
th
marrow and those collected

f VLA 4 per myeloid progenitor collected from the
0

-

.
. bl d If the null hypothesis were true,
from the clrculatmg
00.

.
then any measured differences

VLA-4 expression per myeloid progenitor cell)
(mean
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wouldmost

lik ly be attributable to measurement errors which would be normally
1 e

.
d
nd a mean of zero. If sufficient evidence for rejecting the null hypothesis
distnbute arou
c:

were toun

d (i e ps O05) then any measured differences between the two sample
."
_.
,

populationmeans would most likely be attributable to true differences in the population
means.Thus a p-value of ,;0.05 would indicate that, at least 95% of the time, differences
observedin the experiment reflect true differences in CAM or CD34 expression between
blood andmarrow myeloid progenitors. The paired t-test assumes that the variables
underanalysisare normally distributed and homogeneity of variance.

In order to test for

normality,the Shapiro-Wilks W test was performed on each variable prior to paired t-test
analysis. This statistic is the preferred test of normality as compared with other tests of
normality,such as the Kolmogorov-Smimov

test. In both the Shapiro-Wilks and

Kolmogorov-Smimovtest the null hypothesis states that the respective distribution

is

normal;thus, a significant W or D statistic, respectively, would lead to rejection of the
null hypothesisthat the variable is normally distributed. In order to test for homogeneity
of variance,the Levene Test was performed on each variable prior to paired t-test
analysis. In this test, analysis of variance for each dependent (measured) variable is
perfonnedon the absolute deviations of the values from the respective group means.

The

null hypothesiso f th e L evene test states that the variability between variables is
homogeneous. If a sigm
. .fiicant p-value was obtained (i.e., p,;O.05), then the null
hypothesisof hornogenerty
. 0f variance
.
was rejected.
Analysisof CFU assays (bsu types of colonies
. formed, total colonies formed)
LTCICassays(LTCIC

content of sorted subsets) and binding assays , was performed
...,
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'

· f riance (ANOV A) for multiple measures. In general, the purpose of
usinganalystS0 va
ANOVAis to test for significant differences between sample means; however, as the
nameof this test implies, this test actually compares the variances of each sample.

Under

the null hypothesis, the variance estimated based on within-group variability should be
aboutthe same as the variance due to between-groups variabilty.

For example, the

variabilityof the total number colonies formed/LO" cells plated (within-group variability)
shouldbe about the same as the variability between the total number colonies formed/l O·
sortedcellsof marrow and blood (between-groups variabilty).

Rejection or failure to

rejectthe null hypothesis of the ANOVA test follows the same criteria as previously
describedfor the Student's t-test; that is, a significant F statistic (';0.05) would lead to
rejectionof the null hypothesis with 95% confidence that the differences measured in the
experimentreflect true population differences. Assumptions of the ANOV A test include
normaldistribution and homogeneity of variance of the dependent

(measured) variables.

In general,ANOVA analysis is robust against violations of the assumption of normality

andhomogeneityof variance when 1) N;> 10 and 2) the means of each group do not
correlatewith the standard deviations across groups, respectively.
homogeneity
.

0

Normality and

f variance
.
for each dependent variable was tested using the Shapiro-Wilks

andLevenetest, respectively, as previously described.
Afterobtaining a significant F statistic (';0.05) from ANOVA, it was important to
detenninewho
h
.
IC groups (vanables) were specifically different.

Performance of a series

of t-teststo compare a II possible
. pam
. of means would capitalize on chance m
. th at
, earung
reportedprob bT .
a I ities would actually overestimate the statistical significances of mean
67

differences(Typ

e I error)

Post hoc comparison techniques specifically take into account
.

the fact that more than two samples were taken. In most post hoc comparisons, the
meansof all variables are sorted into ascending order. For each pair of means, the
probabilityunder the null hypothesis of obtaining differences between means of this
magnitude(or greater) given the respective number of samples is then calculated.
Finally, the actual probabilties based on the distribution of the calculated (studentized)
rangeof statistics is calculated and reported. For analysis of specific effects between
variablesdeemed significantly different via ANOVA analysis, Newman-Keuls Test and
CriticalRanges was utilized

The Newman-Keuls Test, like ANOV A, is based on the

studentizedrange statistic. Computationally, the means were sorted into ascending order
andthe probability under the null hypothesis (no differences between means in the
population)of obtaining differences between means of this (or greater) magnitude,

given

the respectivenumber of samples, was determined.
In those analyses in which the assumptions of the parametric tests (paired t-test,
ANOYA, etc.) were violated (e.g. one or more of the variables was not normally
distributed)th
, e nonparametnc.. equrva Ient to the parametric test was utilized for
statisticalanalysis. Th e W·I
..
1 coxon matched pam test

IS

a nonparametric alternative to the

pairedt-test(t-te st for d epen dent samples). The Wilcoxon test assumes that the variables
underexamin atiIOnwere measured on a scale which allows rank ordering of the
observationsbas ed on eac h variable
vari
and that allows rank ordering of the differences
betweenvariables.
t-test.

The obtained p-value is interpreted just as that of the paired samples

TheKruskal-Wallis ANOVA b

y ranks

.

IS
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a nonparametric alternative to ANOV A.

Thistest assumes that the variable under consideration is continuous and was measured
on at least an ordinal scale. This test assesses the hypothesis that the different samples in
the comparison were drawn from the same distribution or from distributions with the
samemedian. If a significant difference was found using the Kruskal-Wallis

ANDY A,

the Mann-Whitney U test, a nonparametric alternative to the t-test was used. In order to
circumventthe comrnittance of Type I error the Bonferroni method was employed

to

determinean acceptable p-value. In this technique, the acceptable p-value of 0.05 was
dividedby the number of comparisons being performed with the Mann-Whitney

U test.

In summary, when the measured variable was normally distributed the parametric
test dictatedby the experiment design (t-tests, ANOY A, or Newman-Keuls

test) was

used. When the measured variable was not normally distributed the nonparametric

tests

wereapplied(Mann-Whitney U test, Kruskall Wallis ANOV A by ranks, or Wilcoxon
matchedpairs test) as dictated by the design of the experiment.
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RESULTS

im 1 differential expression of CAMs betw een marrow and blood

lstrlbution of CAM expressing cells within the C'D34+mye loid
.
01 progenitor
populations of marrow and blood Nucleated cell fractions of paired marrow and blood
im

from either granulocyte-colony

stimulating factor (G-CSF) mobilized patients

or n rm .1 d n rs were enriched for CD34+ cells (Figure 4). The paired specimens were
I b led with monoclonal antibodies (mAb) against CD34, CD45 and one of the following
cell adh ion molecules (CAMs) under study: homing-associated cell adhesion molecule
). very late antigen (VLA-4) or L-selectin (Appendix 4). The individual cell
types

in each ample were differentiated using a method similar to the one originally

reported by telzer et al. (Figure 9). S7 The myeloid progenitor population was gated and
aJ zed for the coexpression of each CAM (RCAM, VLA-4 or L-selectin) with CD34
igure 10).
o ignificant difference (p>005) was detected between the percentage ofCD34'
.'

.

HCAM or L-selectin (paired t-test analysis) between

m eloid progenitors coexpressmg

.

23A) Marrow derived myeloid progenitors from
.
.
( -0 0}7'Wilcoxon Matched Pairs Test)
. .fi
tly hIgher p-.
,
normal donors expressed a Slglll rcan

normal marrow and bloo d (F 19ure
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Figure 23. Qualitative expression ofHCAM,

CD34+

VLA-4, L-seleetin and CD34 on myeloid progenitors

between marrow and blood samples. Paired samples of marrow and blood from either
nonnal donors (n~7) or patients mobilized with G-CSF (n=7) were enriched for CD34+
cells. Blood (gray) and marrow (white) myeloid progenitors were examined flow
cytometricaIly for their coexpression of cell adhesion molecules: HCAM, VLA-4 or
L-selectin with CD34; or their expression of CD34. In normal donors (A), the
percentage of marrow derived myeloid progenitors expressing CD34 was significantly
greater (p=O.OI7) than on circulating myeloid progenitors. In G-CSF primed patients
(B), the percentage of CD34+ myeloid progenitors coexpressing HCAM was
significantly lower (p=O.OI4) on myeloid progenitors residing in the marrow than those
in circulation. Significant differences are indicated with asterisks.
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e (mean±2 x standard error of mean (s.e.m.); 91±2%) ofCD34 than their
percentag
circulatingcounterparts (68±11%; Figure 23A).
In G-CSF mobilized patients, no significant difference (p>005) was found in the
percentageof CD34+ myeloid progenitor cells coexpressing VLA-4, L-selectin or CD34
betweenmarrow and blood (Figure 23B). However, the percentage (mean±2 x
s.e.m.%)ofCD34+ myeloid progenitors coexpressing RCAM was significantly lower
(p=O.OI4;paired t-test) on those residing in the marrow (74±8%) than those in
circulation(89±7%; Figure 23B).
No significant difference (p>O.05) was detected between blood specimens derived
from normal donors and those derived from G-CSF mobilized patients with regard to the
percentageof myeloid progenitors expressing HCAM, VLA-4, L-selectin and CD34
(Figure24). The percentage of marrow derived CD34+ myeloid progenitors
coexpressingHCAM was significantly higher (p=O.002; Student's t-test) on myeloid
progenitorsfrom normal donors than on those from G-CSF mobilized patients
(Figure25). No other significant differences between normal donor and G-CSF
mobilizedpatient marrow derived myeloid progenitors in terms of their coexpression

of

VLA-4 or L-selectin with C034; or expression of CD34 alone (Figure 25).

CAM expression per CD34+myeloid progenitor cell. To quantitate the expression
of CAM or CD34 per CD34+ myeloid progenitor cell, the mean peak channel
fluorescenceof each mar ker

.thiIII the CD34+ myeloid progenitor gated population

WI

was

determined(Figu re 12) . Th e mean channel fluorescence was compared with the QSC
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Figure 24. Comparison of blood specimens derived from normal donors and G-CSF mobilized
patients for qualitative differences in myeloid progenitor cell expression ofHCAM,
VLA-4, L-selectin and CD34. Blood samples obtained from normal donors (n=7;
white) or patients mobilized with G-CSF (n=7; gray) were enriched for CD34+ cells
(same data set as presented in Figure 21). Myeloid progenitors were examined flow
cytometrically for their coexpression of cell adhesion molecules: HCAM, VLA-4 or
L-selectin with CD34; or their expression of CD34. No significant difference (p>Q.05)
was detected between blood specimens derived from normal donors and those derived
from G-eSF mobilized patients with regard to the percentage of myeloid progenitors
expressing HCAM, VLA-4, L-selectin and CD34.
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Figure 25. Comparison of marrow specimens derived from normal donors and G-CSF mobilized
patients for qualitative differences in myeloid progenitor cell expression of HCAM,
VLA-4, L-selectin and C034. Marrow samples obtained from normal donors (n=7;
white) or patients mobilized with G-CSF (n=7; gray) were enriched for C034+ cells
(same data set as presented in Figure 21). Myeloid progenitors were examined flow
cytomettically for their coexpression of cell adhesion molecules: HCAM, VLA-4 or
L-selectio with C034; or their expression of C034. The percentage of marrow derived
CD34+ myeloid progenitors coexpressing HCAM was significantly higher (p=O.002) on
myeloid progenitors from normal donors than on those from G-eSF mobilized patients.
Significant differences indicated by asterisks.
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·
ression standard curves generated for each experiment and the antibody
bead [inear reg
..
it (Abc) units per CD34+ myeloid progenitor was extrapolated
bmdmgeapacr y
(Figure14).
The expression of CD34 per myeloid progenitor cell (mean Abc units ±
2 x s.e.m. )

of normal donor marrow (32113±1 0681) was significantly greater

(p~.0036; paired t-test) than those in circulation (13640±8976),
58%per circulating CD34+ myeloid progenitor (Figure 26A).

an average decrease of
No significant difference

(p>O.05)between normal donor marrow and blood was detected in HCAM, VLA-4 or
L-selectinexpression per CD34+ myeloid progenitor cell (Figure 26A).
In G-CSF mobilized patients, marrow derived CD34+ myeloid progenitor

cells

expressedsignificantly greater (p=0.0007) VLA-4 per cell (mean Abc units ± 2 x s.e.m.;
12966±3482)than those circulating in the blood (7097±3523), an average decrease of
45%per circulating CD34+ myeloid progenitor (Figure 26B).

No significant difference

(p>O.05)between G-CSF mobilized marrow and blood was detected in RCAM,
L-selectinor CD34 expression per CD34+ myeloid progenitor cell (Figure 26B).
CD34+ myeloid progenitors expressed significantly more (p=O.032; Student's
t-test) L-selectin per cell than those derived from G-CSF mobilized patients (Figure 27).
No significantdifference (p>0.05) in the expression ofHCAM

or L-selectin and CD34 ,

or CD34alone per blood derived myeloid progenitor cells was detected (Figure 27). No
significantdiffer ence (0p> .05) was detected between marrow specimens derived from
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Figure Ui. Quantitative expression of HCAM, VLA-4, L-1;electinand CD34 on myeloid progenitors.
to norroal donors (A). myeloid progenitor expression ofCD34, as reflected by antibody
binding capcity (Abc) units, was significantly higher (p-=O.0036)on those residing in the
marrow (while) than on those in circulation (gray). In G-CSF primed patients (B),
drcalating CD34+ myeloid progenitors expressed significantly less (p=O.0007)VLA-4
per cell than those residing in \be marrow. Significant differences indicated by asterisks.
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Figure 27. Comparison of blood specimens derived from normal donors and G-CSF mobilized
patients for quantitative differences in myeloid progenitor cell expression of HCAM,
VLA-4, t-setecnn and CD34. Blood samples obtained from normal donors (n=7; white)
or patients mobilized with G-CSF (0=7; gray) were enriched for CD34+ cells (same data
set as presented in Figure 26). Myeloid progenitors were examined flow cytometrically
for their coexpression of cell adhesion molecules: HCAM, VLA-4 or L-seleetin with
CD34; or their expression of CD34. CD34+ myeloid progenitors from normal donors
expressed significantly more (p=O.032) L-selectin per cell than those derived from G-CSF
mobiliZed patients. Significant differences indicated by asterisks.
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d those derived from G-CSF mobilized

patients

with regard to per cell

nonnal donors an
.
fHCAM,
expresslOn 0

VLA-4 or L-selectin

with CD34; or CD34 expression

alone

(Figure 28)

if

Speci

IC

im 2· clonogenic
at
.

potential and long term culture initiating

cell content

of

marrow and blood

CFUassays of CAA·rCD34+ myeloid progenitor populations from marrow and
blood Nucleated cell fractions of marrow or pooled buffy coat specimens from normal
donors were enriched for CD34+ cells (Figure

4). The specimen

against CD34 and one of the following cell adhesion molecules:
adhesion molecule (RCAM),

very late antigen

for the presence

myeloid progenitors (Figures 9 and 12). The flow cytometer

and minimal cellular complexicity),

criteria:

the CFU cultures were examined and the number ofBFU-E,
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4). The

of CAM+'-CD34+

small size

15). Only samples

whose

analysis of sorted samples)

in Table Three.

CFU GM colonies were enumerated via microscopic

(Appendix

low side scatter (indicating

by flow cytometric

were used to plate CFU assays as summarized

cell

was directed to sort only

CD34+ and CAM+ (Figure

post-sort purity was ;,90% (as determined

homing-associated

(VLA-4) or L-selectin

labelled sample was analyzed flow cytometrically

those cells which displayed the following

was labelled with mAb

After 14 days of culture,
CFU-E, CFU-mix

inspection

(Figures

and

18 and 19).
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Figu", 28. Comparison of marrow specimens derived from normal donors and G-eSF mobilized
patients for quantitative differences in myeloid progenitor cell expression of HCAM,
VLA-4, L-selectin and C034. Marrow samples obtained from normal donors (n=7;
white) or patients mobilized with G-eSF (n=7; gray) were enriched for CD34+ cells
(same data set as presented in Fignre 24). Myeloid progenitors were examined flow
cytometrically for their coexpression of cell adhesion molecules: HCAM, VLA-4 or
Leelectin with CD34; or their expression of CD34. No significant difference (p>O.05)
was detected between marrow specimens derived from normal donors and those derived
from G-CSF mobilized patients with regard to per myeloid progenitor cell expression of
HCAM, VLA-4, L-selectio and C034.
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·.
f rt d CAM+CD34+
myeloidprogenitorsbased on
P and post-sort puntles 0 so e
I . AUpercentage,are pre,ented a' mean± 2 x s.e.m. %e ,

Tablen- ,ort FACS anay"'.
Myeloid
Progenitor
Subset

N

Pre-sort

Post-sort

N

Pre-sort

Post-sort

HCAM+CDW

10

32± 10%

98±2%

6

34 ± 14%

97±2%

VLA-4+CD34+

10

33 ± 16%

97±2%

6

38 ± 24%

96±4%

VLA·4'CDW

9

14±6%

98± 1%

3

14 ± 10%

97±4%

L-selectinTD34+

10

20± 10%

96±2%

5

30 ± 16%

92±2%

L-selectin'CD34+

9

22± 10%

97±2%

3

16± 6%

97±2%

po,t-

Pooled Buffy Coats

Normal
Marrow

Blood derived CAM+!'CD34+myeloid progenitors produced a significantly greater
(p=O.00008; ANDV A) total number of colonies than their respective marrow
counterparts(Figure 29).

Newman-Keuls analysis for specific differences are

summarizedin Table Four. HCAM+CD34+ myeloid progenitors sorted from normal
bloodproduced a significantly greater (p=0.013) total number of colonies (391±128;
mean±2xs.e.m.)than those derived from marrow (202±68; Figure 29 and Table Four).
BloodderivedVLA-4' and Lselectirr CD34+ myeloid progenitors produced a
significantlygreater total number of colonies (310±170, p=0.031; and 355±35,
p=O.0007; respectively) than their marrow counterparts (139±44 and 99±43, respectively;
Figure29 and Table Four).
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K J Test of total colonies formed bv blood versus marrow derived CAM+"
Table Four. Newman- ltor s N S indicates no significant difference (p>o.05) was found between the
34+myeloid progem ors. .,
. .
CD
. bl . therwise the specific p-vaJue " listed,
twO vana es: 0
•

Marrow Derived CD34+ Myeloid Progemtors

Blood Derived
CD34+Myeloid
Progenitor Subset

I-setecnn

BCAM+

L-selectin+
L-selectin'

No significant difference (p>O.05) was detected in the total number of colonies
formed between sorted CD34+ myeloid progenitor subsets derived from blood (n=20)
regardlessof coexpression ofRCAM, VLA-4 or L-se!ectin with CD34 (Figure 30).
Therewas no significant difference (p>0.05) in the total number of colonies formed by
marrowderived CD34+ myeloid progenitors also RCAM., VLA-4+/· or Lsselectin'"
(Figure31).
No significant difference (p>O.05) in colony type distribution (i.e., %CFU-E
versus%BFU-E, etc. of total colonies formed) was found between blood and marrow
derivedHCAM+,VLA-4', Lselectin" or Lvselectin CD34+ myeloid progenitors
(Figures32-35). Marrow derived VLA-4+CD34+ myeloid progenitors produced a
.f
19U1lcantlygreater percentage (p=O.013; Student's t-test) of CFU-GM colonies

s'

(24±110;..
2
...
, mean ± x s.e.m.%) than their circulating counterparts (4±2%; Figure 36).
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Figure 30,

Total colonies formed from blood derived CAM+/-CD34+

myeloid progenitors.

There was no significant difference (p>O.05) in the total number of colonies formed
between sorted CD34+ myeloid progenitor subsets derived from blood (n=20)
regardless of coexpression of HCAM, VLA-4 or L-seleclin with CD34.
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Figure 31. Total colonies formed from marrow derived CAM+I-CD34+

myeloid progenitors.

There

was no significant difference (p>O.05) in the total number of colonies formed between
sorted CD34+ myeloid progenitor subsets derived from marrow (n=38) regardless of
coexpression ofHCAM, VLA-4orL-selectin with CD34.
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Figure 32. Comparison of CFU colony distribution between blood and marrow derived
HCAM+CD34+ myeloid progenitors.

CD34+ myeloid progenitors

coexpressing HCAM

were flow cytometrically sorted from blood and marrow specimens derived from normal
donors and plated into CFU assays. No significant difference (p>O.05) in colony type
distribution (represented as a percentage of total CFU colonies scored) was found
between blood (gray; n=20) and marrow (white; n=38) derived HCAM+CD34+ myeloid
progenitors.
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•

Mean Blood
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Comparison of CFU colony distribution between blood and marrow derived
VLA-4-CD34+ myeloid progenitors. CD34+ myeloid progenitors not expressing
VLA-4 (that is, VLA-4-) were flow cytometrically sorted from blood and marrow
specimens derived from normal donors and plated into CFU assays. No significant
difference (p>O.05) in colony type distribution (represented as a percentage oftotaI
CFU colonies scored) was found between blood (gray; n=20) and marrow (white;
n=38) derived VLA-4-CD34+ myeloid progenitors.
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Figure 34. Comparison of CFU colony distribution

Blood

0

Mean

Marrow

between blood and marrow derived

L-s electin+CD34+ myeloid progenitors. CD34+ myeloid progenitors coexpressing
L-selectin were flow cytometrically sorted from blood and marrow specimens derived
from normal donors and plated into CFU assays. No significant difference (p>O.05) in
colony type distribution (represented as a percentage of total CFU colonies scored) was
found between blood (gray; n=20) and marrow (white; n=38) derived L-selectin+CD34+
myeloid progenitors.
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Figure35. Comparison of CFU colony distribution between blood and marrow derived
L-selectin-<::D34+myeloid progenitors. CD34+ myeloid progenitors not expressing
L-seleetin (that is, L-selectin-) were flow cytometrically sorted from blood and marrow
SPecimensderived from normal donors and plated into CFU assays. No significant
diflerence (p>O.05) in colony type distribution (represented as a percentage of total CFU
colonies scored) was found between blood (gray; n=20) and marrow (white; n=38) derived
L-selectin-<::D34+myeloid progenitors.
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Figure 36. Comparison of CFU colony distribution between blood and marrow derived
VLA-4+CD34+ myeloid progenitors. CD34+ myeloid progenitors coexpressing VLA-4
were flow cytometrically sorted from blood and marrow specimens derived from normal
donors and plated into CFU assays. Marrow (white; n=38) derived CD34+ myeloid
progenitors coexpressing VLA-4 produced a significantly greater (p=O.013) percentage
of CFU-GM colonies than their circulating counterparts (gray; n=20). Significant
differences indicated by asterisks.
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In blood samples, the percentage of total colonies comprised of CFU-E, when
. between sorted CAM+1'CD34+ myeloid progenitors, was not significantly
companng
different(Figure 37A). Blood derived CD34+ myeloid progenitors coexpressing
L_selectinformed a significantly lower (p=0.002; ANOVA) percentage ofBFU-E
coloniesthan all other sorted CAM+1-CD34+ myeloid progenitors (Figure 37B); while
fanninga significantly greater (p=O.004; ANOVA) percentage of CFU-GM colonies
(Figure38A). The Newman-Keuls test was used to determine the specific differences
betweensorted CAM+CD34+ myeloid progenitors with regard to the percentage of
BFU-Ecoloniesformed (Table Five). L-selectin+CD34+ myeloid progenitors from blood
fanneda significantly lower percentage ofBFU-E colonies (33±9%;mean±2xs.e.m.)

than

HCAM+(60±4%; p=O.007), VLA-4+ (66±16%; p=O.Ol), VLA-4- (68±3%; p=0.005), or
l-selectin' (61±12%; p=0.006) CD34+ myeloid progenitors (Figure 37B and Table Four).
The specificdifferences between percentage of CFU-GM colonies formed from sorted
CAM+CD34+
myeloid progenitors in vitro were determined using Newman-Keuls
analysisand are summarized in Table Six. Lvselcctin" CD34+ myeloid progenitors from
bloodformeda significantly greater percentage of CFU-GM colonies (53±28%;
mean±2x s.e.m.) than CD34+ myeloid progenitors also HCAM+ (12±9%; p=0.009),
VLA-4+(4±2%;p=O.Oll), VLA-4' (8±9%; p=0.007), or L-selectin' (5±2%; p=0.014;
Figure38A and Table Six).

No significant difference (p>0.05) between blood derived

SOrtedCAM+1'CD34+myeloid progenitors was found in the percentage of total colonies
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Figure 37. Percentage of CFU-E and BFU-E colonies formed from blood derived
CAM+I-CD34+ myeloid progenitors. Flow cytometrically sorted CD34+ myeloid
progenitors either expressing the cell adhesion molecnle of interest (CAM+) or not
(CAM-) were plated into CFU assays (n=20; pooled buffy coat samples). No
significant difference between sorted CAM+I-CD34+ myeloid progenitors was found
in the percentage of total colonies comprised of CFU-E colonies (A). CD34+
myeloid progenitors coexpressing L-seIectin formed a significantly lower (p=O.002;
indicated by asterisk) percentage of BFU-E colonies than all other sorted
CAM+I-CD34+ myeloid progenitors (B).
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Figure 38. Percentage of CFU-GM and CFU-mix colonies formed from blood derived
CAM+/-CD34+ myeloid progenitors. Flow cytometrically sorted CD34+ myeloid
progenitors either expressing the cell adhesion molecule of interest (CAM+) or not
(CAM-) were plated into CFU assays (n=20; pooled buffy coat samples). CD34+
myeloid progenitors ooexpressing L-selectin formed a significantly greater
(P=O.004; indicated by asterisk) percentage of CFU-GM colonies than all other
CAM+/-CD34+ myeloid progenitors sorted (A). No significant difference (p>O.05)
between sorted CAM+/-CD34+ myeloid progenitors was found in the percentage of
total colonies comprised of CFU-mix colonies (B).
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uls Test of %BFU-E colouies formed by blood CAM+i-CD34+ myeloid
an Ke
'
Table F'IVeo Newm
S ' di- ates no significant difference (p>o.05) was found between tbe two variables;
enitors. N.. 10 Ie
.,
prog , tb ,pecific p_value IS listed.
olherwllle e

CD34+
Myeloid
Progenitor
Subset

BCAM+

VLA-4+

VLA-4-

Lsselectin"

L-selectin-

0.007

N.S.

BCAW
N.S.

VLA-4+

N.S.

VLA-4-

N.S.

lrselectin +

0.007

0.0109

lrselectin-

N.S.

N.S.

N.S.

T'ble Sir Newman-Keuls Test of %CFU-GM colonies formed' by blood CAM+'-CD34+ myeloid
progonit
... , N.S, indicates no significant difference (p>o.05) was found between tbe two variables;
otherwisethe specific p-value is listed.

CD34+
Myeloid
Progenitor
Subset

BCAM+

VLA-4+

VLA-4-

BCAM+
VLA-4+

L-selectin+

L-selectin-

0.009

N.S.
N.S.

VLA-4'

N.S.

L-selectin+

0.009

0.0118

L-selectin-

N.S.

N.S.

N.S.
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I

. d fCFU-mix colonies (Figure 38B). Analysis of marrow samples revealed no
coDlpnse0
.
d''''' rences (p>0.05) in the percentage of total colonies comprised ofCFU-E,
SigOlficant
me
GM or CFU-mix colonies (Figures 39 and 40).
BFU-E, CFULTCICassays ojCAM1'CD34+ myeloid progenitor populations from marrow and
blood Nucleatedcell fractions of marrow or pooled buffy coat specimens from normal
donorswereenriched for CD34+ cells, labelled with mAbs, and sorted flow
cytometrically
(Figures 4 and IS). Sorted cells were assayed using the LTCIC assay
platedatdilutionsof3, 10,30,100,300

and 1000 cells per well in replicates of24 wells

ontoirradiatedmouse bone marrow stroma capable of maintaining human hematopoiesis
ill vitro (Figure20). After 5 weeks of culture, each well was individually harvested and

subcultured
intoCFU assays. After 14 days, those wells containing at minimum of one
colonyperwellwere scored as positive. A standard curve of the number of cells plated
perwellversuspercent positive wells was plotted on semi-log paper for each subset and
thenumberof LTCIC per 106 sorted CD34 + myeloid progenitor cell was determined
(Figure21)
No significant difference (p>0.05) in LTCIC enrichment was found between
CAM'CD34+ myeI 01id progenitors
'
'
sorted from blood (n=9; Figure
41A), All subtypes of
CD34' mye101id progenitors
'
sorted from normal marrow and plated onto M2-1 OB4

stromaconta'med significantly
' ,
different (p=0.0027; ANaVA) enrichments ofLTCICs
perl 0' sonedce11s (F'igure 41B), The Newman-Keuls test was used to determine the

Specific
differences b etween LTCIC enrichment of sorted marrow derived CAM+CD34+
myeloidp
,
rogemtors(Table Seven),
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Figure 39. Percentage of CFU-E and BFU-E colonies formed from marrow derived
CAM+/-eD34+ myeloid progenitors. Flow cytometrically sorted CD34+ myeloid
progenitors either expressing the cell adhesion molecule of interest (CAM+) or not
(CAM-) were plated into CFU assays (n~38; normal marrow specimens). No
significant difference (p>O.05) between sorted CAM+/-CD34+ myeloid progenitors
was found in the percentage of total colonies comprised of CFU-E (A) or BFU-E
colonies (B).
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A. CFU·GM Colonies
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Figure 40. Percentage of CFU-GM and CFU -mix colonies formed from marrow derived
CAM+!-CD34+ myeloid progenitors. Flow cytometrically sorted CD34+ myeloid
progenitors either expressing the cell adhesion molecule of interest (CAM+) or not
(CAM-) were plated into CFU assays (n=38; normal marrow specimens). No
significant difference (p>O.05) between sorted CAM+!-CD34+ myeloid progenitors
was found in the percentage of total colonies comprised of CFU-GM (A) or CFU-mix
colonies (B).
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Figure41. LTCIC content of sorted CAM+CD34+ myeloid progenitors. Blood (A) or marrow
(8) from normal donors was enriched for CD34+ cells. Viable CD34+ myeloid
progenitors coexpressing HCAM, VLA-4 or L-selectin with CD34 were flow
cytometrically sorted at purities greater than or equal to 90% purity and plated into
LTCIC assays. After seven weeks of culture on M2-10B4 stroma, the number of
LTCIC per 10(6) sorted CAM+CD34+ myeloid progenitor cells plated was
determined. No significant difference (p>o.05; Kruskall-Wallis ANDV A) in LTCIC
content was found between CAM+CD34+ myeloid progenitors sorted from blood
(~=9). CAM+CD34+ myeloid progenitors sorted from normal marrow (n=9) were
SIgnificantly different (p=O.0027; ANOV A; indicated by asterisks) from one another.
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u uls Test of LTCIC enrichment of sorted marrow derived CAM+CD34+
e
Newmao-n.
N S'
plies. no significant difference (p>O.05) was found between the two
'd rogenitors. ., am
lOyelOlP b rwise the specific p_value is listed.
"ariables; ot e

rable seven..

CD34+ Myeloid
Progenitor
Subset

L-selectin+

0.0029
BCAM+
VU-4+

0.0029

L-selectin+

CD34+myeloid progenitors derived from normal marrow coexpressing
containeda significantly greater enrichment

L-selectin

6

of L TCIC per 10 sorted cell (41 ,667±9,642;

mean±2 x s.e.m.) than those coexpressing

HCAM (16,467±2,467;

p=0.0029)

(22,333±3,697;p=O.0044). No significant

difference (p>0.05) in LTCIC enrichment

foundbetween blood and marrow CAM+ CD34+ myeloid progenitors

Specificaim 3: demonstration

or VLA-4
was

(Figure 42).

that VLA-4 binds CD34+ myeloid progenitors

to

fibronectin.

Binding of CD34+ myeloid progenitors tofibronectin
fractionsof pooled buffy coat specimens

in vitro. Nucleated

cell

from normal donors were enriched for CD34 +

cells(Figure 4). Cells were plated (50 x 103 cells/well) in replicates of four into four
treatmentgroups. One group was plated onto blank, non-coated
nonspecificbind'mg contro Is. The remammg
. . three treatment

wells to serve as

groups consisted

of cells

platedonto FN coated wells which
... received either buffer alone, mAb against the 04
chainof VLA-4

.
..
, or an isotype identical mAb not specific for the 04 chain of the VLA-4
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Figure 42.

III 25%-75%

o

Blood

25%-75% Marrow

Comparison of L TCIC content between blood and marrow derived CAM+CD34+
myeloid progenitors. Blood (gray) and marrow (white) specimens obtained from
normal donors were enriched for CD34+ cells. Viable CD34+ myeloid progenitors
coexpressing HCAM, VLA-4 or L-selectin were flow cytometrically sorted at
purities greater than or equal to 90% and plated into LTCIC assays. After seven
weeks, the number of LTCIC per 10(6) sorted CAM+CD34+ myeloid progenitor
cells plated was determined. No significant difference (p>O.05) in LTCIC
enrichment was found between blood (gray; n=9) and marrow (white; n=9)
CAM+CD34+ myeloid progenitors.
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.
heterodlmer

Aft

stimulating adhesion to FN at 37"C, non-adherent and adherent cells
er
uantitated and labelled for flow cytometric analysis of C034, C045 and

wereharvested, q

. n The percentage of CD34+ or VLA-4+CD34+ myeloid progenitors
VLA-4expresslO .
.
boundin each replicate was determined.
No significant difference (p>0.05) was found in the percentage of C034+ myeloid
progenitorsbound to FN in each of the four treatment groups (Figure 43A). The
adhesionofVLA-4+CD34+ myeloid progenitors was significantly different (p=0.0002,
ANOVA; Figure 43B). Post hoc comparisons to determine specific differences between
thebindingof VLA-4+CD34+ myeloid progenitors in each treatment group (and their
respectivep-values; Newman-Keuls Test) were performed and are summarized in Table
Eight.A significantly greater (p=0.0005) percentage (mean ± 2 x s.e.m.) of
VLA-4+CD34+
myeloid progenitors bound to FN coated wells than to blank, noncoated
wells(41±8%)regardless of the addition of buffer alone, (71±12%, p=0.0005), anti-a4
mAb(SS±8%,p=0.0403), or anti-IgG2a (71±8%, p=0.0008; Figure 43B and Table
Eight).There was no significant difference (p>0.05) between the percentage of
VLA-4'CD34+
myeloid progenitors bound to FN coated wells treated with buffer alone
(7IiI2%) and those treated with anti-IgG2a (71±8%). The difference between the
percentageofVLA-4+CD34+ myeloid progenitors bound to FN coated wells treated with
anti-lgG2a(71±8%) and those treated with anti-a4 mAb (55±8%) approached
significance(p=0 .0528) . Th e addition
..
ofmAb against the 0:4 chain ofVLA-4
significantly(p-.
-0 0249) reduced the binding ofVLA-4+CD34+ myeloid progenitors to

FN by an average 0f 16% (Figure 43B and Table Eight). Analysis of
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Figure 43. Results of adhesion assay. CD34+ cell enriched fractions from pooled buffy
coat samples were plated into wells of microtiter plates (replicates offour;
n- ) into one of the following well treatment groups: uncoated (Blank),
coated with fibronectin alone (FN), FN and mAbs against the a;4 chain of the
VLA-4 heterodimer (FN+anti-a4), or FN and an isotype identical mAb
(FN+anti-IgG2a) (A) Adhesion of viable CD34+ myeloid progenitors did not
significantly differ (p>0.05) between treatment groups. (B) Adhesion of
viable VLA-4+CD34+ myeloid progenitors was significantly different
(p=O,0002) as revealed by ANOVA. Intergroup differences shown in Table
Eight.
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VL -4' D 4' m eloid progenitor adhesion was not possible bee

thi
ause

minorit

the

myel rd P

T.bl< It
COJ.!'

I

genit

tal

IS

11
ce

type was a

D34' cells (see Figure 23) and the number ofVLA-4'CD34+

r ells recoverable

from the adhesion assay was highly variable.

.". ",.,,·lUu'"
T.. t of the percentage ofVLA-4+CD34+ myeloid progenitors bound.
I1cIl d fr <tlon. of pooled buffy coats were plated into adhe.ion assays, The adhesion of
VLA...,(' 0
myelo d progenltors w ...... e.. ed in uncoated wells (Blank); and FN coated wells with
burr.... "t1-44, nr ntl-lgC2 a, The specific p-values are listed.
l.

Blank

Blank

FN coated

0.0005

FN coated
+ anti-a.4

FN coated
+ anti-I G2a

0.0403

0.0008

0.0005

0.9391

0.0403

0.0528

0.0008

0.9391
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DISCUSSION

Hematopoietic

stem cell transplantation

for the treatment of hematopathologies
successful allogeneic

transplants

that time, hematopoietic

fir t b
.
s ecame a feasible clinical therapy

in the late 1960' s WIt
. h the advent of several

in pediatric pat"len ts WIith iImmunodeficiencies.
"
11-'" Since

stem cell transplantation

hematologic as well as nonhematologic

has b een app I'ied to a vanety
of

malignancies, benign pathologies and genetically

determined diseases."
In spite of the many advances
problems remain.

in the field of stem cell transplant therapy, many

Two specific problems

stem cells mobilized

into the peripheral

are efficiency and quantity of hematopoietic
circulation for collection prior to transplant and

the role of stem cell homing to the marrow during post-transplant hematopoietic
recovery. Understanding

the role that cel1 adhesion molecules play in stem cell

peripheralization and homing could lead to the development of enhanced stem cell
collection protocols and post-transplant

engraftment rates, respectively.

This study was designed to address the h ypo
adhesion molecules

th

- that modulation of the cell
eSIS

HCAM, VLA-4 and L-se1ectin playa role in regulating

hematopoietic progenitor

.
cel1 traffickmg
.

th

arrow and the peripheral

between
em
VLA-4 and L_selectin in HPC trafficking

circulation. This hypotheSIzed role for HCAM,
103

predictsthat I) differences

in the surfac

.
e expresSion of CAMs (HCAM

selectin)are d tectable between marrow

and bl

d
00

CAM expr

ing

034'

cells can be functionall

.
specimens, 2) both high and low

d
y emonstrated to be hematopoietic

progenitors and 3) VLA-4 mediates the adhesion of CD34+
component

the hematopoietic

Specificaim I: differential

marrowand blood

II
.
ce s to fibronectin, a

microenvironment.

expression

of CAMs between marrow and blood

In order to test the prediction
express cell adhesion

, VLA-4, or L-

molecules

that hematopoietic

progenitors will differentially

as a function of their anatomic derivation, samples of

034' myeloid progenitors from the same individual were examined for

differencesin expression of CAMs
molecule, very late antigen-4
. I Importance
.
potentia

The CAMs examined, homing-associated cell adhesion

and L-selectin,

were selected because of established or

on hematoooi
ematopOletic. stem ce IIs. 34-3. '41-44

Half of the paired samples were obtained from patients treated with mobilizing doses
of granulocyte-colony
collected for autologous

.
stimulatmg
transplant

.
currentor previous histological

All of these patients had breast carcinoma and no

.
eVidence

paired samples were obtained

(G CSF) f:
whom bone marrow was being
rom

factor

f di ase in their marrow. The remainder of the
ise
. ally normal individuals donating bone
from hemato Iogre
0

The nucleated cell fraction of each specimen was
marrow for allogeneic

transplant
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isolatedand enriched for CD34' cells CD34'
.
.
ennched spe .
.
.
.
cnnens were analyzed via flow
cytomctry In conjunction with standards of antiibody bi di
. order to d t
m mg In
. the
e ermme
amountof ntibody b und per cell.
In n nnal individuals,

marrow CD34+

mye

I'd

01

.
progemtor cells bound more

anti- 034 per cell than those in the blood , sugge stimg a greater expression of CD34 on
liP s riding

in the marrow than those in circulation . Alth ou gh th e function
. of CD34

is not k:n wn, tudi
CD34deer
.

have shown that as myeloid progenitors

es suggesting
6S,66

maturauon.

mature their expression of

an inverse relationship between CD34 expression and HPC

•

mce marrow derived HPCs expressed more CD34 per cell than those

whichhave entered the circulation,

one is tempted to speculate that marrow myeloid

progenitors are les mature, that is have greater hematopoietic
myeloidprogenitors.

Assessment

of in vitro hematopoietic

executionof specific aim two) demonstrated

potential, than circulating

potential (investigated in

that blood derived HPCs rather than those

derivedfrom marrow had the greatest short-term hematopoietic
difference in long-term

hematopoietic

potential was found between blood and marrow.

.'
Thesefindings illustrate that physiologic
characterization of HPC maturation

.
blood and marrow

In

t

may

playa more critical role in

state than CD34 expression.

f HCAM,
terms

compartmen

. .
no slgmficant

In normal individuals,

potential. No significant

. ti difference was found between
quantlta rve

VLA-4 or L-selectin expression per CD34'

0

. _
myeloidprogenitor cell. Lack of a slgmficant

titative differences in CAM
quan

.
ion during marrow ingress and egress
expression suggests that modulatIOn of express
. .
.
. CAM ligand affinity/avidity
. .'
Ives alteratIOns III
during steady-state hematopOieSIS IllVO
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ratherthan quantitative decreases i
rf
n su ace expression Anal .
.
...
.
YS1Sof CAM li and
affinltyl vidit Interactions on marr
g
ow versus blood derived HPc
.
Swould provide insight
into thi i u .

In
expr

. mobilized

ed m re

patients , marrow denved
.
CD34+ mye I01id progenitors

A-4 antigens per cell th an t hose m
. circulation, a finding which is

consistentwith the hypothesis
exi ISbetween HP

that a quantitative

residing in the marrow

consistentwith the hypothesis

difference
. of VLA-4
erence iin the expression

.. circulation.
.
an d th ose m

These data are

that down-regulati on or mas king ofVLA-4 expression is

involvedin the release of HPCs from the marrow mi
.
rmcroenvironment

.
into
the peripheral

circulation.
o ignificant

quantitative

differences

in HCAM or L-selectin expression

betweenthe blood and marrow CD34· myeloid progenitors from G-CSF mobilized
individuals were detected

These findings suggest that during G-CSF mobilization

down-regulation of surface expression

of HCAM or L-selectin does not playa direct role

in egress from the marrow into the peripheral
statehematopoiesis, the lack of significant
L-selectin expression

circulation.

Thus, as in the case of steady-

quantitative differences in HCAM or

between G-CSF mobilized blood and marrow suggests that

alterations in H AM or L-selectin avidity and/or affinity might playa more critical role
.
10

HPC trafficking than quantitative

.
.
piously
changes in expreSSIOn. rev

h
HCAMexpression on circulating mature lymp ocytes an

reported studies of

d L_selectin expression on
.

.

. h I
key role in HPC hom mg.
HPCshave suggested that these CAMs mIg t P ay a
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30,38

...

nal i ofH

and L-selecti n mediated

ti

underno

adh

.
esion of HPCs to marrow endoth li

di .
con iuons would provide insight into th

e tum

e role of these CAMs in HPC

homing

The bove conclusions
characteri ti

0

were based on expenments
.

the epitopes recognized

antigenand th mechanism
mAb to tructurally

. which th
. molecular
e precise

In

by the mAb s, t h e number of epitopes
.
per

of mAb binding

to antigen were not len own. The binding of

repeated motifs , such as the o-helices and np-P ltd
ea e sh eels of L-

selectin, could have resulted in more than one mAb binding to eac h an figen, 416364
"
If this
hadoccurred then the antigen binding observed flow cytometrically would have reflected
a greater number of antigens present than actually occurring in nature. Although the
amountof m b bound to each cell would be linearly proportional to the number of
antigenspr ent, care must be taken in the interpretation of the number of CAMs present
per cell. The Q

bead assay was utilized to demonstrate

marrowper cell expression

CAM under examination,

in terms of which cell type expressed more or less of the
Thus, this assay allows for relevant comparisons of antigenic

expression rather than determination

In a

differences between blood and

ddi
th I' "
Ilion to e irrntations

.
....
(patching, capping and pinocytosis

of exact number of antigens present per cell,
0

f th QSC bead assay redistribution of antigens
e
'

d
.
mplexes on the cell surface)
of antibo y-antIgen co

.
. d durin flow cytometric analysis, In
couldhave adversely affected detectIOn of antibo Y
g
.
'
th el1 surface and to minimize
orderto prohibit the redistributIOn of antIgens on e c
. d out at 4°C. In addition,
.
I
. ents were came
conformational changes of antigen, al expenm
.
.d a metabolic inhibitor.
all mAbs utilized in these experiments

contained sodIum azi e,
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j{ d th cpr

uti ns n t been employed

fl

ow cytometric analysis of CAM
.
and CD34
exP
n per m el id progenitor cell might h
.
ave estimated cell ....
surtacs expression to be
much low lh n th t present in nature
.

,

o umm rize the above data and concl
mobiliz.edmrr

4' myeloid progenitor

th ir circul tin

unterparts

cells expressed more VLA 4
.
- antigen than

These findings support the h ypo thesi
. of
esis th at modulation

VLA-4 pi

an important

HP

rom the marrow microenvironment.

egr

differen

in H.....I"UVl

individual d
th e

.

usions regarding speerific
ai
IC aim one, G-CSF

role in HPC peripheralization,

nd L-selectin

namely during G-CSF induced

The lack of detectable quantitative

expression in G-CSF mobilized or normal

n t rule out the possibility

that alterations in affinity and/or avidity of

for their ligands as a mechanism

for HPC peripheralization and homing.

The finding that n rmal marrow CD34+ myeloid progenitor cells expressed more CD34

than th

derived from blood suggested

the blood; h wever, subsequent

that marrow HPCs are less mature than those in

experiments

These data are con i tent with the hypothesis
.
hematopoietic progenitor
.

WIth regard to quantitative

(specific aim two) refuted this possibility.
stated in specific aim one that

..
II
the cell adhesion molecules only
cells differentia Yexpress
..
Quantitative changes in
changes III VLA-4 expressIOn.

.
db tween the marrow and blood of
and L- electin expressIOn were not observe
e
.
h t ther mechanisms of
either normal or
F mobilized individuals suggestmg mat o

He

modulating

.
I·
function might be playmg a ro e
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HPC trafficking.
10

peelfic im 2 cl n

genic potential

and I
ong term cultu

'"

re Inttlating cell COntent of

m8lTOW nd bl

o(

I th

prediction

that both high an d Iow CAMe

funCli n II dem n trated to be hematopoietic
m8lTOwr

bufTy coat specimens

.
xpressmg CD34+ cells can be

.
progemtors, nucleated cell fractions of

from no rma I donors were enriched for CD34+

cell

imens were labeled with mAb against CD34 an d one of the following cell

adh i nm

ul

and

ned 0

W

H AM, VLA-4 or L-selectin.
metrically

c

The labeled samples were analyzed

for CAM+1-CD34+ mye I'Old progenitors. Post-sort purities

of ~9O"10

34' myeloid progenitors

assay to assess

rt-term hematopoietic
4' myeloid progenitors

were used to plate colony forming unit

potential.
sorted from either blood or marrow produced

hematopoietic col nics in vitro. These findings are consistent with the prediction that
-,_ 034'

each of the
demonstrated

(0

myeloid progenitor

be hematopoietic

progenitors

populations examined can be functionally
with regard to establishment of short-term

hematopoi i in itro.
irculating

AM"'C034+

1

I

(i.e., HCAM" VLA-4+ . or L-selectin+ .) myeloid

. than those derived from marrow.
I
f
progenitors produced a greater total number 0 co omes
bI
od derived CD34+ myeloid
df
The greatest total number of colonies were forme
rom 0
. _ VLA 4- VLA-4+ or L-selectin+
progenitors also H AM'; followed by L-selectlfi,
-,
.
f
d more colonies than those
subtypes
ince AM-CD34' myeloid progenitors ocme
that VLA-4 and L_selectin expression
expressing VL

-4 or L-selectin,

this data suggests
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fibronectin
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To test the prediction that VLA-4
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mediates binding to fibronectin,

nucleatedcell fractions of pooled buffy coat specimens from normal donors were
enrichedfor CD34+ cells. Cells were plated into adhesion assays in which a4 mediated
bindingof VLA-4 to FN was blocked with monoclonal
boundCD34+or VLA-4+CD34+ myeloid progenitors

antibodies. The percentage of
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failedto bind FN in these experiments
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specificallystimulate Bl integrin function."

or GM-CSF, the binding of these

manner suggesting that cytokines
Perhaps, just as their marrow counterparts,

bloodderived C034' myeloid progenitors require cytokine activation of VLA-4 in order
to fullybind FN. Elucidation

of the role of cytokine activation of VLA-4 and other /31

integrinson HPCs warrants further study,
The adhesion assay contained intrinsic limitations,
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to FN,
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To summarize the proposed model of the role of HCAM, VLA-4 and L-selectin
in HPC trafficking, peripheralization of HPCs can be promoted by quantitative decreases

insurfaceexpression ofVLA-4.

Thus HPCs may enter the vasculature by virtue of their

namely
decr easedability to bind components of the marrow microenvironment,
.
fibronectinand VCAM-I expressing stromal cells. Peripheralization does not appear to
involvequantitative decreases in HCAM expression per HPC but instead involves
alterationsin HCAM affinity for hyaluronan and collagen.

With regard to HPC homing

tothemarrowmicroenvironment, modulation of L-selectin and/or HCAM affinity rather
thanquantitativechanges in surface expression most likely plays an important role in

HPC homingto marrow endothelial cells. Once bound to endothelium by L-selectin,
VLA-4 mediated adhesion to endothelial cells expressing VCAM-I may enable HPC

transmigrationinto the marrow microenvironment.

Thus, these studies implicate the cell

adhesionmolecule VLA-4 and L-selectin as possessing an important role in HPC
trafficking,while the role of HCAM in this complex process remains speculative
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I PRJ
IPLES OF DENSITY

GRADIENT CENTRIFUGATION

Th
II wing principles of density gradient centrifugation were outlined by
m in the I te I 60's apply for both Ficoll-Paque® Plus and Polymorphp 41
rep
\I
I 01 treated blood is layered on the density gradient solution and centrifuged
rt
. od 0 lime, Differential migration during centrifugation results in the
fIe
ntaining different cell types (Figure 4), The bottom layer contains
hich h ve been aggregated by the gradient and, therefore, sediment
lhr ugh the gradient. The layer immediately above the erythrocyte layer
m u g.ranulocytes which at the osmotic pressure of the gradient solution attain
I en ugh to migrate through the gradient layer.
f their lower density, the lymphocytes are found at the interface
B u lasma and the gradient with other slowly sedimenting particles (platelets
bet'\\'tlell Ih I
e lymphocytes are then recovered from the interface and subjected to
onocv hin
.J tep WIith a balanced salt solution to remove any platelets, gradient and
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RPHOLOGIC

CHARACT
ERIZATION

OF HEMA

TOLOGIC

lIowi.ng m rphologic characteristics were '.
.
t I I cell types within all cytocentrifi
~tt~~zed in the differentiation of
uge s Ide preparations stained with
'I'

oblll t • (diamete -15-20 urn) moderate bl .
n ngranular cytoplasm which'
r h' uish, unevenly stained
. h
IS 19 ter next to the n I
th
pe ip cry Nucleus is round and stains
d
.
uc eus an at the
nu I Iiare usually demonstrable.
pre ommantly red. Two or more

r m

te - (diamcter=15-20
urn) cytoplasm sam
.
ex pt distinct dark-blue or reddish-blue granu~eCOs
olofrattonbasl
mhyeloblast
I
.
vana e s apes are
p.. ern
uc eus IS round and large relative to cytoplasm Nucleoli rna be
VI ible but are usually indistinct.
y
10

te, neutrophilic

- Small islands of reddish granules present in cytoplasm
nt to nucleus. Nuclei are round, oval or flattened on one side.
li are indistinct.

dj
uel

mvs
te, neutrophilic
- Slightly smaller than myelocytes. Small, pinkishblue granules present in cytoplasm. Nucleus slightly indented.
B nd n utrophil - Slightly smaller than metamyelocytes. Cytoplasmic granules
are mall, evenly distributed and stain various shades of pink and blue.
Th opposite edges of the nucleus become approximately parallel for an
appreciable distance giving a horseshoe appearance.
III nt
n utrophil - Similar size to neutrophilic band. Cytoplasmic
granules present as described for band neutrophil. Nucleus is separated
into definite lobes with a very-narrow filament or strand connecting the
if

I b

'

inophil

ize comparable

>

to segmented neutrophil.

Cytoplasm contains

large spherical granules which stain red.
.
pbiJ _ 'ire comparable to segmented neutrophil. Cytoplasm con~ms ~arge.
. h
. d p purplish-blue to dark purp e-re .
pherical granules whic stam ee'
ith their diameters 3-4 times those
M OOC'''''' lightly larger than neutrophl l s ~I fi Id Dull gray-blue variably
f erythr cytes in the same microscoPiC :e h . ped) with blunt pseudopods.
h ped cytoplasm (most are round or ova s a

has brain like convolutIOns.

ueleu

lar cytoplasm with large

0 urn) Blue, nOlngran'~e is comparable to diameler
yt lasrn Nuc eus Sl
nucleu in relatIOn to c op .. '
leoli
of n rmal erythrocytes
No VISible nuc
.

mpbo

t

-

(diameter=7-1
.
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2 M

RPHOLOGIC

CHARA
CTERIzATION

TI

(

OF

UED)

HEMATOLOGIC

)'te· (diameter= 15-25 urn N
yl pi m usually has roun~ oroongrlanUlar,translucent dark bl
Iff
Irm
.
va shap
.h
'
- ue
I ro dargms with distinct perinUclea e ~'t smooth or slightly
.
un and eccentric
Nrc
ear zone. Nucl .
Pr no 01 blast _ V' ibl
.. uclear chromatin i
et are small,
151
e nucleoh. Chromati
s CO~se and lumpy .
. y1 plasm stains light blue to dark
n s:rand are lInear and distinct
In pI mocytes)
, roya -blue color (similar to th .
Oil
at seen
B sop b I normoblast
- Sm a IIer than pronormobl
unge but predominant color is bl
D'
ast. Cytoplasm has reddish
b the' coarsenmg of the chro fue. ISllnguishabl e from pronormoblast
nucl
Ii
rna In pattern and ill-defined or absent
PI

III

o

o

0

P I bromatic

normoblast
- smaller th
plasm
Nuclear ch
" an normoblast, have relatively more
rornatm ISthickened and
I I
ucleoli are not visible.
irregu ar y condensed.

y1

0

rth

brom
am

tic normoblast
.

. predominantly red with minimal
- C ytop Iasm IS

unt of residual blue. Nucleus is small and has a nonlinear clum ed
hr mattn structure or a solid blue-black degenerated nucleus.
p
t - (diameter-so-B urn) biconcave discs which appear in stained
om.
as red, Circular objects with distinct, smooth margins. The
inten ity of the stain in the central portion where the cell is thinnest is less
than at the thicker marginal area.
ryo yte - Large cells with relatively large amount of cytoplasm,
und hapes, even margins and multiple nuclei. Chromatin pattern of
nucleus i linear, coarse with distinct spaces between the chromatin
strand
ytoplasm contains numerous small, uniformly distributed
granul
of reddish-blue hue. Numerous cytoplasmic granules, two or
more nuclei
_ (diameter=l-4
urn) Cytoplasmic fragmentofa megakaryocyte
hich has multiple pointed filaments or tentacle lik~ protrusions. Round,
oval
pindle and discoid shapes with smooth margms are also
bs~able.
Cytoplasm stains light blue and ~ntains variable numbers of

r m ocyt

mall, blue granules which tend to aggregate

The m rp 10 ical characteristics
ic cell b

center.

. d b
e derived from an altas of
descnbe
a ove wer

Diggs et al."
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APPENDIX3. CITRATE PHOSPHATE DEXTROSE SOLUTION
I)

2)
3)
4)

Combined the following in volumetric flask and increased volume with
distilled water (dHzO) to - 50 mL:
166 g sodium citrate (dihydrate) USP
161 g dextrose (monohydrate) USP
188 mg citric acid (anhydrous) USP
140 mg monobasic sodium phosphate (monohydrate) USP
Adjusted pH to 7.2 to 7.4 using 2 M NaOH
Increased volume to 63 mL with dHzO.
Stored in sterile reservoir at 4 "C until use.
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AR Y OF FLOW CYTOMETRIC
LONAL ANTIBODY
'ample
ription

1I

Nurn

1

'II •

LABELLING

Antibody

Conjugate

FITC

PE

PerCP

---

---

---

2

ells·

CDl4

IgGl

---

3

ells·

IgGI

CD14

---

Cells "

IgGI

IgGl

CD45

S

Cells>

IgGI

IgG2a

CD45

6

ells>

CD44

CD34

CD45

7

ells>

CD49d

CD34

CD45

ells·

CD62L

CD34

CD45

9

Q

Beads

CD44

---

---

10

QSC Beads

CD49d

---

---

II

QSC Beads

CD62L

---

---

CD34

---

12

•
ean

Monoclonal

FLUOROCHROME

ed

- lDIph-

~Bead

m
ft r

-

Purpose
Compensation for
autofluorescence
Compensation for
emmission spectra
overlap
of each
fluorochrome
Analysis of CAM
expression on
CD34' myeloid
progenitors

Standardization of
mAb binding

b ffy coat specimens
n nucIear cells denved from marr ow, blood or u
4' cells
m bs were added

...

PH

[6
dH)

PHA TE BUFFER FOR STERILE SORTING

I. I 3 x 10" M KCI, 41 x 10" M Na2HP0 , 7.1 x 10-4M KH PO. in

10'

4

2

mbine

the following

dl tilled water (dH,O)

400

g

0097
7

in volumetric flask and increased volume with
to -470 mL:

aCI
K I
a1HPO,

KH,P04

pH

djusred
to 7.2 to 7.4 using 2 M NaOH
ed volume to I L with dH 0

In
)

2

terile filtered with 0.2 zzrn Nalgene filtration system (Nalge Company,
ester, NY)
.
I red in sterile reservoir at 4 °C until use.
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